Frequencies for first 10,000 rows of pt variable in reac2007q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 14 0.14 0.14 ABDOMINAL ADHESIONS | 1 0.01 0.15 ABDOMINAL DISCOMFORT | 4 0.04 0.19 ABDOMINAL DISTENSION | 13 0.13 0.32 ABDOMINAL MASS | 1 0.01 0.33 ABDOMINAL PAIN | 46 0.46 0.79 ABDOMINAL PAIN LOWER | 3 0.03 0.82 ABDOMINAL PAIN UPPER | 37 0.37 1.19 ABDOMINAL RIGIDITY | 1 0.01 1.20 ABDOMINAL STRANGULATED HERNIA | 1 0.01 1.21 ABDOMINAL SYMPTOM | 1 0.01 1.22 ABDOMINAL TENDERNESS | 6 0.06 1.28 ABNORMAL BEHAVIOUR | 7 0.07 1.35 ABNORMAL CLOTTING FACTOR | 1 0.01 1.36 ABNORMAL DREAMS | 2 0.02 1.38 ABORTION INDUCED | 7 0.07 1.45 ABORTION MISSED | 1 0.01 1.46 ABORTION SPONTANEOUS | 12 0.12 1.58 ABSCESS | 4 0.04 1.62 ABSCESS INTESTINAL | 1 0.01 1.63 ABSCESS JAW | 1 0.01 1.64 ABSCESS LIMB | 1 0.01 1.65 ACANTHAMOEBA INFECTION | 1 0.01 1.66 ACARODERMATITIS | 1 0.01 1.67 ACCIDENT | 1 0.01 1.68 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 1.69 ACCIDENTAL EXPOSURE | 1 0.01 1.70 ACCIDENTAL OVERDOSE | 11 0.11 1.81 ACIDOSIS | 4 0.04 1.85 ACOUSTIC NEUROMA | 1 0.01 1.86 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 1.88 ACTIVITIES OF DAILY LIVING IMPAIRED | 3 0.03 1.91 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 1.93 ACUTE HEPATIC FAILURE | 3 0.03 1.96 ACUTE LEUKAEMIA | 1 0.01 1.97 ACUTE MYELOID LEUKAEMIA | 3 0.03 2.00 ACUTE MYOCARDIAL INFARCTION | 2 0.02 2.02 ACUTE PRERENAL FAILURE | 1 0.01 2.03 ACUTE PULMONARY OEDEMA | 1 0.01 2.04 ACUTE RESPIRATORY DISTRESS SYNDROME | 5 0.05 2.09 ACUTE SINUSITIS | 1 0.01 2.10 ADDISON'S DISEASE | 1 0.01 2.11 ADENOCARCINOMA PANCREAS | 1 0.01 2.12 ADENOIDAL HYPERTROPHY | 1 0.01 2.13 ADNEXA UTERI MASS | 1 0.01 2.14 ADRENAL DISORDER | 1 0.01 2.15 ADRENAL INSUFFICIENCY | 1 0.01 2.16 ADRENAL NEOPLASM | 2 0.02 2.18 ADVERSE DRUG REACTION | 5 0.05 2.23 ADVERSE EVENT | 6 0.06 2.29 AFFECT LABILITY | 4 0.04 2.33 AGEUSIA | 3 0.03 2.36 AGGRESSION | 16 0.16 2.52 AGITATION | 19 0.19 2.71 AGNOSIA | 1 0.01 2.72 AGRANULOCYTOSIS | 5 0.05 2.77 AKATHISIA | 6 0.06 2.83 AKINESIA | 1 0.01 2.84 ALANINE AMINOTRANSFERASE INCREASED | 58 0.58 3.42 ALBUMIN GLOBULIN RATIO ABNORMAL | 1 0.01 3.43 ALBUMIN GLOBULIN RATIO DECREASED | 1 0.01 3.44 ALBUMIN URINE PRESENT | 1 0.01 3.45 ALCOHOL INTERACTION | 1 0.01 3.46 ALCOHOL POISONING | 3 0.03 3.49 ALCOHOL USE | 4 0.04 3.53 ALCOHOLISM | 1 0.01 3.54 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.55 ALOPECIA | 7 0.07 3.62 ALOPECIA EFFLUVIUM | 1 0.01 3.63 ALOPECIA TOTALIS | 1 0.01 3.64 ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID I.. | 1 0.01 3.65 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.66 ALVEOLITIS ALLERGIC | 1 0.01 3.67 AMAUROSIS FUGAX | 1 0.01 3.68 AMBLYOPIA | 1 0.01 3.69 AMENORRHOEA | 3 0.03 3.72 AMMONIA INCREASED | 1 0.01 3.73 AMNESIA | 16 0.16 3.89 AMYLOIDOSIS | 1 0.01 3.90 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 3.91 ANAEMIA | 48 0.48 4.39 ANAEMIA MACROCYTIC | 2 0.02 4.41 ANAEMIA NEONATAL | 2 0.02 4.43 ANAEMIA POSTOPERATIVE | 1 0.01 4.44 ANAESTHESIA | 1 0.01 4.45 ANAESTHETIC COMPLICATION | 2 0.02 4.47 ANAESTHETIC COMPLICATION NEUROLOGICAL | 1 0.01 4.48 ANAL DISCOMFORT | 1 0.01 4.49 ANAL FISSURE | 1 0.01 4.50 ANAPHYLACTIC REACTION | 11 0.11 4.61 ANAPHYLACTIC SHOCK | 6 0.06 4.67 ANAPHYLACTOID REACTION | 1 0.01 4.68 ANGER | 8 0.08 4.76 ANGINA PECTORIS | 8 0.08 4.84 ANGINA UNSTABLE | 1 0.01 4.85 ANGIOEDEMA | 9 0.09 4.94 ANGIOLIPOMA | 1 0.01 4.95 ANGIOPATHY | 2 0.02 4.97 ANGLE CLOSURE GLAUCOMA | 1 0.01 4.98 ANHEDONIA | 3 0.03 5.01 ANKLE FRACTURE | 2 0.02 5.03 ANORECTAL DISORDER | 1 0.01 5.04 ANOREXIA | 40 0.40 5.44 ANOSMIA | 5 0.05 5.49 ANOVULATORY CYCLE | 1 0.01 5.50 ANOXIC ENCEPHALOPATHY | 3 0.03 5.53 ANTI-ERYTHROCYTE ANTIBODY | 1 0.01 5.54 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.55 ANTIBODY TEST POSITIVE | 1 0.01 5.56 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.57 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 5.58 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 5.61 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAP.. | 1 0.01 5.62 ANXIETY | 44 0.44 6.06 AORTIC ANEURYSM | 3 0.03 6.09 AORTIC ARTERIOSCLEROSIS | 2 0.02 6.11 AORTIC STENOSIS | 2 0.02 6.13 AORTIC VALVE DISEASE | 2 0.02 6.15 AORTIC VALVE INCOMPETENCE | 3 0.03 6.18 AORTIC VALVE SCLEROSIS | 1 0.01 6.19 APALLIC SYNDROME | 1 0.01 6.20 APATHY | 2 0.02 6.22 APGAR SCORE ABNORMAL | 1 0.01 6.23 APGAR SCORE LOW | 1 0.01 6.24 APHASIA | 8 0.08 6.32 APHONIA | 1 0.01 6.33 APHTHOUS STOMATITIS | 1 0.01 6.34 APLASIA PURE RED CELL | 1 0.01 6.35 APLASTIC ANAEMIA | 3 0.03 6.38 APNOEA | 1 0.01 6.39 APPARENT LIFE THREATENING EVENT | 1 0.01 6.40 APPENDICECTOMY | 1 0.01 6.41 APPENDICITIS PERFORATED | 2 0.02 6.43 APPLICATION SITE DISCOLOURATION | 1 0.01 6.44 APPLICATION SITE ERYTHEMA | 1 0.01 6.45 APPLICATION SITE PRURITUS | 1 0.01 6.46 APPLICATION SITE RASH | 1 0.01 6.47 APPLICATION SITE SWELLING | 1 0.01 6.48 APPLICATION SITE VESICLES | 1 0.01 6.49 ARACHNOIDITIS | 1 0.01 6.50 ARRHYTHMIA | 16 0.16 6.66 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 6.67 ARTERIAL BYPASS OPERATION | 1 0.01 6.68 ARTERIAL GRAFT | 1 0.01 6.69 ARTERIAL STENOSIS | 1 0.01 6.70 ARTERIAL STENT INSERTION | 1 0.01 6.71 ARTERIAL THROMBOSIS LIMB | 1 0.01 6.72 ARTERIOSCLEROSIS | 1 0.01 6.73 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 6.74 ARTERIOSPASM CORONARY | 3 0.03 6.77 ARTERITIS | 1 0.01 6.78 ARTHRALGIA | 40 0.40 7.18 ARTHRITIS | 10 0.10 7.28 ARTHRITIS BACTERIAL | 2 0.02 7.30 ARTHRITIS INFECTIVE | 1 0.01 7.31 ARTHROPATHY | 7 0.07 7.38 ARTHROPOD BITE | 2 0.02 7.40 ARTIFICIAL CROWN PROCEDURE | 1 0.01 7.41 ASCITES | 10 0.10 7.51 ASPARTATE AMINOTRANSFERASE INCREASED | 51 0.51 8.02 ASPERGILLOSIS | 5 0.05 8.07 ASPIRATION | 1 0.01 8.08 ASPIRATION BONE MARROW | 1 0.01 8.09 ASTHENIA | 71 0.71 8.80 ASTHENOPIA | 1 0.01 8.81 ASTHMA | 13 0.13 8.94 ATELECTASIS | 9 0.09 9.03 ATRIAL FIBRILLATION | 16 0.16 9.19 ATRIAL FLUTTER | 3 0.03 9.22 ATRIAL SEPTAL DEFECT | 1 0.01 9.23 ATRIAL TACHYCARDIA | 1 0.01 9.24 ATRIAL THROMBOSIS | 2 0.02 9.26 ATRIOVENTRICULAR BLOCK | 2 0.02 9.28 ATRIOVENTRICULAR BLOCK COMPLETE | 4 0.04 9.32 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 9.35 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.36 ATROPHY | 1 0.01 9.37 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 9.38 AUTOIMMUNE DISORDER | 2 0.02 9.40 AUTOIMMUNE THYROIDITIS | 1 0.01 9.41 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 9.42 AXILLARY VEIN THROMBOSIS | 1 0.01 9.43 AZOTAEMIA | 2 0.02 9.45 B-CELL LYMPHOMA | 1 0.01 9.46 BACK DISORDER | 1 0.01 9.47 BACK INJURY | 1 0.01 9.48 BACK PAIN | 35 0.35 9.83 BACTERAEMIA | 1 0.01 9.84 BACTERIA STOOL IDENTIFIED | 1 0.01 9.85 BACTERIAL INFECTION | 6 0.06 9.91 BACTERIAL SEPSIS | 1 0.01 9.92 BACTERIURIA | 1 0.01 9.93 BALANCE DISORDER | 10 0.10 10.03 BAND NEUTROPHIL COUNT INCREASED | 1 0.01 10.04 BAND NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 10.05 BASAL CELL CARCINOMA | 2 0.02 10.07 BEDRIDDEN | 4 0.04 10.11 BENIGN BREAST NEOPLASM | 1 0.01 10.12 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 10.13 BILE DUCT CANCER | 1 0.01 10.14 BILE DUCT STONE | 1 0.01 10.15 BILIRUBIN CONJUGATED INCREASED | 2 0.02 10.17 BIOPSY BLADDER NORMAL | 1 0.01 10.18 BIOPSY LIVER ABNORMAL | 1 0.01 10.19 BIPOLAR DISORDER | 4 0.04 10.23 BIPOLAR I DISORDER | 1 0.01 10.24 BITE | 1 0.01 10.25 BLADDER DISORDER | 1 0.01 10.26 BLADDER INJURY | 1 0.01 10.27 BLADDER OBSTRUCTION | 1 0.01 10.28 BLADDER SPASM | 2 0.02 10.30 BLAST CELL COUNT INCREASED | 1 0.01 10.31 BLEPHARITIS | 2 0.02 10.33 BLINDNESS | 10 0.10 10.43 BLINDNESS CORTICAL | 1 0.01 10.44 BLINDNESS DAY | 1 0.01 10.45 BLINDNESS TRANSIENT | 5 0.05 10.50 BLINDNESS UNILATERAL | 5 0.05 10.55 BLISTER | 10 0.10 10.65 BLISTER INFECTED | 1 0.01 10.66 BLOOD ALBUMIN DECREASED | 5 0.05 10.71 BLOOD ALDOSTERONE DECREASED | 1 0.01 10.72 BLOOD ALDOSTERONE INCREASED | 1 0.01 10.73 BLOOD ALKALINE PHOSPHATASE INCREASED | 24 0.24 10.97 BLOOD AMYLASE INCREASED | 4 0.04 11.01 BLOOD ANTIDIURETIC HORMONE INCREASED | 1 0.01 11.02 BLOOD BETA-D-GLUCAN ABNORMAL | 1 0.01 11.03 BLOOD BICARBONATE INCREASED | 1 0.01 11.04 BLOOD BILIRUBIN INCREASED | 17 0.17 11.21 BLOOD BLISTER | 1 0.01 11.22 BLOOD CALCIUM DECREASED | 3 0.03 11.25 BLOOD CHLORIDE DECREASED | 2 0.02 11.27 BLOOD CHLORIDE INCREASED | 2 0.02 11.29 BLOOD CHOLESTEROL | 1 0.01 11.30 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.31 BLOOD CHOLESTEROL INCREASED | 12 0.12 11.43 BLOOD CHOLINESTERASE DECREASED | 2 0.02 11.45 BLOOD COUNT ABNORMAL | 1 0.01 11.46 BLOOD CREATINE INCREASED | 2 0.02 11.48 BLOOD CREATINE PHOSPHOKINASE INCREASED | 26 0.26 11.74 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 11.75 BLOOD CREATININE | 1 0.01 11.76 BLOOD CREATININE DECREASED | 2 0.02 11.78 BLOOD CREATININE INCREASED | 21 0.21 11.99 BLOOD CULTURE POSITIVE | 3 0.03 12.02 BLOOD DISORDER | 2 0.02 12.04 BLOOD ELECTROLYTES DECREASED | 1 0.01 12.05 BLOOD FIBRINOGEN DECREASED | 3 0.03 12.08 BLOOD FOLATE ABNORMAL | 1 0.01 12.09 BLOOD GASES ABNORMAL | 1 0.01 12.10 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.11 BLOOD GLUCOSE DECREASED | 5 0.05 12.16 BLOOD GLUCOSE FLUCTUATION | 3 0.03 12.19 BLOOD GLUCOSE INCREASED | 27 0.27 12.46 BLOOD HIV RNA INCREASED | 1 0.01 12.47 BLOOD IMMUNOGLOBULIN G INCREASED | 2 0.02 12.49 BLOOD IRON DECREASED | 1 0.01 12.50 BLOOD IRON INCREASED | 2 0.02 12.52 BLOOD LACTATE DEHYDROGENASE INCREASED | 14 0.14 12.66 BLOOD LACTIC ACID | 1 0.01 12.67 BLOOD LACTIC ACID INCREASED | 3 0.03 12.70 BLOOD MAGNESIUM DECREASED | 4 0.04 12.74 BLOOD PARATHYROID HORMONE DECREASED | 1 0.01 12.75 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.76 BLOOD PH INCREASED | 1 0.01 12.77 BLOOD PHOSPHORUS DECREASED | 2 0.02 12.79 BLOOD POTASSIUM DECREASED | 14 0.14 12.93 BLOOD POTASSIUM INCREASED | 3 0.03 12.96 BLOOD PRESSURE ABNORMAL | 2 0.02 12.98 BLOOD PRESSURE DECREASED | 12 0.12 13.10 BLOOD PRESSURE DIASTOLIC DECREASED | 3 0.03 13.13 BLOOD PRESSURE DIASTOLIC INCREASED | 1 0.01 13.14 BLOOD PRESSURE FLUCTUATION | 2 0.02 13.16 BLOOD PRESSURE IMMEASURABLE | 1 0.01 13.17 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 13.19 BLOOD PRESSURE INCREASED | 27 0.27 13.46 BLOOD PRESSURE SYSTOLIC INCREASED | 6 0.06 13.52 BLOOD PROLACTIN INCREASED | 2 0.02 13.54 BLOOD SODIUM DECREASED | 15 0.15 13.69 BLOOD SODIUM INCREASED | 1 0.01 13.70 BLOOD TEST ABNORMAL | 2 0.02 13.72 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.73 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 13.74 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 13.75 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 13.82 BLOOD UREA DECREASED | 2 0.02 13.84 BLOOD UREA INCREASED | 10 0.10 13.94 BLOOD URIC ACID DECREASED | 1 0.01 13.95 BLOOD URIC ACID INCREASED | 2 0.02 13.97 BLOOD URINE PRESENT | 4 0.04 14.01 BLOODY DISCHARGE | 1 0.01 14.02 BODY DYSMORPHIC DISORDER | 1 0.01 14.03 BODY MASS INDEX INCREASED | 1 0.01 14.04 BODY TEMPERATURE DECREASED | 1 0.01 14.05 BODY TEMPERATURE INCREASED | 6 0.06 14.11 BONE DEBRIDEMENT | 1 0.01 14.12 BONE DENSITY DECREASED | 1 0.01 14.13 BONE DISORDER | 8 0.08 14.21 BONE EROSION | 1 0.01 14.22 BONE FORMATION DECREASED | 1 0.01 14.23 BONE LESION | 1 0.01 14.24 BONE MARROW FAILURE | 12 0.12 14.36 BONE MARROW ISCHAEMIA | 1 0.01 14.37 BONE MARROW MYELOGRAM ABNORMAL | 1 0.01 14.38 BONE MARROW PLASMACYTE COUNT INCREASED | 1 0.01 14.39 BONE MARROW TOXICITY | 3 0.03 14.42 BONE NEOPLASM MALIGNANT | 1 0.01 14.43 BONE PAIN | 10 0.10 14.53 BONE SCAN ABNORMAL | 1 0.01 14.54 BOVINE TUBERCULOSIS | 1 0.01 14.55 BRADYCARDIA | 20 0.20 14.75 BRADYKINESIA | 1 0.01 14.76 BRAIN CONTUSION | 1 0.01 14.77 BRAIN DEATH | 3 0.03 14.80 BRAIN HERNIATION | 1 0.01 14.81 BRAIN MASS | 1 0.01 14.82 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 14.83 BRAIN OEDEMA | 4 0.04 14.87 BRAIN STEM HAEMORRHAGE | 2 0.02 14.89 BRAIN STEM SYNDROME | 1 0.01 14.90 BREAKTHROUGH PAIN | 3 0.03 14.93 BREAST CANCER | 13 0.13 15.06 BREAST CANCER FEMALE | 9 0.09 15.15 BREAST CANCER IN SITU | 1 0.01 15.16 BREAST CANCER MALE | 1 0.01 15.17 BREAST CANCER METASTATIC | 2 0.02 15.19 BREAST CANCER RECURRENT | 1 0.01 15.20 BREAST CANCER STAGE I | 1 0.01 15.21 BREAST CANCER STAGE III | 1 0.01 15.22 BREAST CYST | 1 0.01 15.23 BREAST DISCHARGE | 1 0.01 15.24 BREAST DISORDER | 1 0.01 15.25 BREAST DISORDER FEMALE | 1 0.01 15.26 BREAST ENLARGEMENT | 1 0.01 15.27 BREAST MASS | 1 0.01 15.28 BREAST PAIN | 2 0.02 15.30 BREAST TENDERNESS | 2 0.02 15.32 BREATH SOUNDS ABNORMAL | 1 0.01 15.33 BRONCHITIS | 9 0.09 15.42 BRONCHITIS CHRONIC | 1 0.01 15.43 BRONCHOPNEUMONIA | 4 0.04 15.47 BRONCHOSPASM | 2 0.02 15.49 BRONCHOSTENOSIS | 2 0.02 15.51 BRUGADA SYNDROME | 1 0.01 15.52 BULLOUS LUNG DISEASE | 1 0.01 15.53 BUNDLE BRANCH BLOCK LEFT | 2 0.02 15.55 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 15.57 BURNING SENSATION | 17 0.17 15.74 BURNING SENSATION MUCOSAL | 1 0.01 15.75 BURNS FIRST DEGREE | 1 0.01 15.76 BURSITIS | 1 0.01 15.77 C-REACTIVE PROTEIN INCREASED | 12 0.12 15.89 CACHEXIA | 2 0.02 15.91 CAECITIS | 1 0.01 15.92 CAESAREAN SECTION | 15 0.15 16.07 CALCIUM IONISED INCREASED | 1 0.01 16.08 CALCULUS URETERIC | 1 0.01 16.09 CANDIDIASIS | 6 0.06 16.15 CARBOHYDRATE ANTIGEN 125 INCREASED | 1 0.01 16.16 CARBON DIOXIDE DECREASED | 1 0.01 16.17 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 16.18 CARDIAC ARREST | 17 0.17 16.35 CARDIAC DISORDER | 14 0.14 16.49 CARDIAC FAILURE | 14 0.14 16.63 CARDIAC FAILURE ACUTE | 2 0.02 16.65 CARDIAC FAILURE CHRONIC | 1 0.01 16.66 CARDIAC FAILURE CONGESTIVE | 24 0.24 16.90 CARDIAC MURMUR | 1 0.01 16.91 CARDIAC PACEMAKER INSERTION | 3 0.03 16.94 CARDIAC TAMPONADE | 2 0.02 16.96 CARDIAC VALVE DISEASE | 1 0.01 16.97 CARDIO-RESPIRATORY ARREST | 15 0.15 17.12 CARDIOMEGALY | 7 0.07 17.19 CARDIOMYOPATHY | 4 0.04 17.23 CARDIOPULMONARY FAILURE | 1 0.01 17.24 CARDIOTOXICITY | 1 0.01 17.25 CARDIOVASCULAR DISORDER | 11 0.11 17.36 CARNITINE DECREASED | 1 0.01 17.37 CAROTID ARTERY OCCLUSION | 2 0.02 17.39 CARPAL TUNNEL SYNDROME | 1 0.01 17.40 CARTILAGE INJURY | 1 0.01 17.41 CATARACT | 8 0.08 17.49 CATARACT OPERATION | 1 0.01 17.50 CATATONIA | 1 0.01 17.51 CATECHOLAMINES URINE INCREASED | 1 0.01 17.52 CATHETER RELATED COMPLICATION | 4 0.04 17.56 CATHETER RELATED INFECTION | 1 0.01 17.57 CATHETER SITE INFECTION | 1 0.01 17.58 CATHETERISATION CARDIAC | 1 0.01 17.59 CAUSTIC INJURY | 1 0.01 17.60 CELLULITIS | 9 0.09 17.69 CELLULITIS STAPHYLOCOCCAL | 1 0.01 17.70 CENTRAL LINE INFECTION | 1 0.01 17.71 CENTRAL NERVOUS SYSTEM INFLAMMATION | 1 0.01 17.72 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 17.73 CENTRAL NERVOUS SYSTEM STIMULATION | 1 0.01 17.74 CEREBRAL ARTERY EMBOLISM | 1 0.01 17.75 CEREBRAL ATROPHY | 6 0.06 17.81 CEREBRAL CYST | 1 0.01 17.82 CEREBRAL HAEMATOMA | 1 0.01 17.83 CEREBRAL HAEMORRHAGE | 13 0.13 17.96 CEREBRAL INFARCTION | 17 0.17 18.13 CEREBRAL ISCHAEMIA | 2 0.02 18.15 CEREBROVASCULAR ACCIDENT | 46 0.46 18.61 CEREBROVASCULAR DISORDER | 2 0.02 18.63 CEREBROVASCULAR SPASM | 1 0.01 18.64 CEREBROVASCULAR STENOSIS | 1 0.01 18.65 CERVIX CANCER METASTATIC | 1 0.01 18.66 CHANGE OF BOWEL HABIT | 1 0.01 18.67 CHAPPED LIPS | 1 0.01 18.68 CHARLES BONNET SYNDROME | 1 0.01 18.69 CHEILITIS | 2 0.02 18.71 CHEMICAL POISONING | 1 0.01 18.72 CHEST CRUSHING | 1 0.01 18.73 CHEST DISCOMFORT | 19 0.19 18.92 CHEST PAIN | 47 0.47 19.39 CHEST X-RAY ABNORMAL | 4 0.04 19.43 CHEYNE-STOKES RESPIRATION | 1 0.01 19.44 CHILLS | 14 0.14 19.58 CHOKING | 1 0.01 19.59 CHOLANGITIS | 4 0.04 19.63 CHOLANGITIS ACUTE | 1 0.01 19.64 CHOLANGITIS SCLEROSING | 1 0.01 19.65 CHOLECYSTECTOMY | 2 0.02 19.67 CHOLECYSTITIS | 5 0.05 19.72 CHOLECYSTITIS ACUTE | 1 0.01 19.73 CHOLECYSTITIS CHRONIC | 1 0.01 19.74 CHOLECYSTITIS INFECTIVE | 2 0.02 19.76 CHOLELITHIASIS | 10 0.10 19.86 CHOLESTASIS | 4 0.04 19.90 CHOLESTEROSIS | 1 0.01 19.91 CHONDROPATHY | 1 0.01 19.92 CHOREA | 2 0.02 19.94 CHORIOAMNIONITIS | 1 0.01 19.95 CHORIORETINOPATHY | 6 0.06 20.01 CHROMATOPSIA | 1 0.01 20.02 CHROMATURIA | 6 0.06 20.08 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 20.10 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 20.11 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 9 0.09 20.20 CHRONIC SINUSITIS | 1 0.01 20.21 CIRCULATORY COLLAPSE | 6 0.06 20.27 CIRRHOSIS ALCOHOLIC | 1 0.01 20.28 CITROBACTER INFECTION | 1 0.01 20.29 CLAVICLE FRACTURE | 2 0.02 20.31 CLONUS | 1 0.01 20.32 CLOSTRIDIAL INFECTION | 4 0.04 20.36 CLOSTRIDIUM DIFFICILE COLITIS | 3 0.03 20.39 COAGULATION FACTOR VIII LEVEL INCREASED | 1 0.01 20.40 COAGULATION FACTOR XIII LEVEL DECREASED | 1 0.01 20.41 COAGULATION TEST ABNORMAL | 1 0.01 20.42 COAGULATION TIME PROLONGED | 2 0.02 20.44 COAGULOPATHY | 6 0.06 20.50 COARCTATION OF THE AORTA | 1 0.01 20.51 COGNITIVE DISORDER | 5 0.05 20.56 COGWHEEL RIGIDITY | 1 0.01 20.57 COLD AGGLUTININS POSITIVE | 1 0.01 20.58 COLD SWEAT | 4 0.04 20.62 COLITIS | 10 0.10 20.72 COLITIS ISCHAEMIC | 3 0.03 20.75 COLITIS ULCERATIVE | 8 0.08 20.83 COLLAGEN DISORDER | 1 0.01 20.84 COLLAPSE OF LUNG | 1 0.01 20.85 COLON ADENOMA | 1 0.01 20.86 COLON CANCER | 4 0.04 20.90 COLONIC POLYP | 3 0.03 20.93 COLONOSCOPY ABNORMAL | 1 0.01 20.94 COMA | 17 0.17 21.11 COMMUNICATION DISORDER | 1 0.01 21.12 COMPLETED SUICIDE | 14 0.14 21.26 COMPRESSION FRACTURE | 1 0.01 21.27 CONDITION AGGRAVATED | 28 0.28 21.55 CONDUCTION DISORDER | 1 0.01 21.56 CONFUSIONAL STATE | 33 0.33 21.89 CONGENITAL ANOMALY | 3 0.03 21.92 CONGENITAL BRAIN DAMAGE | 1 0.01 21.93 CONGENITAL HAND MALFORMATION | 1 0.01 21.94 CONGENITAL HEART VALVE DISORDER | 2 0.02 21.96 CONGENITAL HYDRONEPHROSIS | 1 0.01 21.97 CONGENITAL HYPOTHYROIDISM | 1 0.01 21.98 CONGENITAL MULTIPLEX ARTHROGRYPOSIS | 1 0.01 21.99 CONJUNCTIVAL OEDEMA | 1 0.01 22.00 CONJUNCTIVITIS | 1 0.01 22.01 CONSCIOUSNESS FLUCTUATING | 1 0.01 22.02 CONSTIPATION | 21 0.21 22.23 CONTRACTED BLADDER | 2 0.02 22.25 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 22.26 CONTUSION | 9 0.09 22.35 CONVERSION DISORDER | 1 0.01 22.36 CONVULSION | 50 0.50 22.86 COOMBS TEST POSITIVE | 1 0.01 22.87 COORDINATION ABNORMAL | 7 0.07 22.94 CORNEAL DISORDER | 1 0.01 22.95 CORONARY ARTERY DISEASE | 6 0.06 23.01 CORONARY ARTERY INSUFFICIENCY | 1 0.01 23.02 CORONARY ARTERY OCCLUSION | 3 0.03 23.05 CORONARY ARTERY PERFORATION | 1 0.01 23.06 CORONARY ARTERY STENOSIS | 1 0.01 23.07 CORRECTIVE LENS USER | 1 0.01 23.08 COUGH | 13 0.13 23.21 CREPITATIONS | 3 0.03 23.24 CROHN'S DISEASE | 4 0.04 23.28 CRYING | 11 0.11 23.39 CRYOGLOBULINAEMIA | 1 0.01 23.40 CRYPTOGENIC ORGANISING PNEUMONIA | 3 0.03 23.43 CSF PROTEIN DECREASED | 1 0.01 23.44 CULTURE URINE POSITIVE | 1 0.01 23.45 CUSHING'S SYNDROME | 1 0.01 23.46 CUTANEOUS LEISHMANIASIS | 1 0.01 23.47 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 23.48 CYANOSIS | 4 0.04 23.52 CYST | 1 0.01 23.53 CYSTITIS | 3 0.03 23.56 CYTOLYTIC HEPATITIS | 4 0.04 23.60 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 1 0.01 23.61 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 23.62 CYTOMEGALOVIRUS INFECTION | 5 0.05 23.67 CYTOMEGALOVIRUS OESOPHAGITIS | 1 0.01 23.68 CYTOMEGALOVIRUS TEST POSITIVE | 2 0.02 23.70 DACRYOCYSTORHINOSTOMY | 1 0.01 23.71 DANDRUFF | 1 0.01 23.72 DANDY-WALKER SYNDROME | 1 0.01 23.73 DEAFNESS | 7 0.07 23.80 DEAFNESS BILATERAL | 2 0.02 23.82 DEAFNESS NEUROSENSORY | 1 0.01 23.83 DEAFNESS TRANSITORY | 1 0.01 23.84 DEAFNESS UNILATERAL | 2 0.02 23.86 DEATH | 54 0.54 24.40 DECREASED ACTIVITY | 2 0.02 24.42 DECREASED APPETITE | 17 0.17 24.59 DECREASED INTEREST | 1 0.01 24.60 DECUBITUS ULCER | 4 0.04 24.64 DEEP VEIN THROMBOSIS | 19 0.19 24.83 DEFAECATION URGENCY | 1 0.01 24.84 DEFORMITY | 2 0.02 24.86 DEHYDRATION | 43 0.43 25.29 DELAYED RECOVERY FROM ANAESTHESIA | 5 0.05 25.34 DELIRIUM | 15 0.15 25.49 DELUSION | 3 0.03 25.52 DEMENTIA | 3 0.03 25.55 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 25.56 DEMYELINATING POLYNEUROPATHY | 1 0.01 25.57 DEMYELINATION | 3 0.03 25.60 DENTAL CARIES | 1 0.01 25.61 DENTAL EXAMINATION ABNORMAL | 1 0.01 25.62 DENTAL TREATMENT | 1 0.01 25.63 DEOXYPYRIDINOLINE URINE INCREASED | 1 0.01 25.64 DEPENDENCE | 4 0.04 25.68 DEPERSONALISATION | 2 0.02 25.70 DEPRESSED LEVEL OF CONSCIOUSNESS | 27 0.27 25.97 DEPRESSED MOOD | 4 0.04 26.01 DEPRESSION | 42 0.42 26.43 DEPRESSION SUICIDAL | 2 0.02 26.45 DEPRESSIVE SYMPTOM | 1 0.01 26.46 DEREALISATION | 2 0.02 26.48 DERMAL CYST | 1 0.01 26.49 DERMATITIS ALLERGIC | 3 0.03 26.52 DERMATITIS BULLOUS | 4 0.04 26.56 DERMATITIS EXFOLIATIVE | 5 0.05 26.61 DERMATOMYOSITIS | 1 0.01 26.62 DEVELOPMENTAL DELAY | 2 0.02 26.64 DEVICE FAILURE | 1 0.01 26.65 DEVICE INTERACTION | 1 0.01 26.66 DEVICE MALFUNCTION | 1 0.01 26.67 DIABETES INSIPIDUS | 2 0.02 26.69 DIABETES MELLITUS | 12 0.12 26.81 DIABETES MELLITUS INADEQUATE CONTROL | 3 0.03 26.84 DIABETES MELLITUS INSULIN-DEPENDENT | 1 0.01 26.85 DIABETIC COMA | 3 0.03 26.88 DIABETIC COMPLICATION | 2 0.02 26.90 DIABETIC KETOACIDOSIS | 4 0.04 26.94 DIABETIC NEPHROPATHY | 1 0.01 26.95 DIABETIC RETINOPATHY | 1 0.01 26.96 DIAGNOSTIC PROCEDURE | 1 0.01 26.97 DIALYSIS | 12 0.12 27.09 DIARRHOEA | 70 0.70 27.79 DIARRHOEA HAEMORRHAGIC | 3 0.03 27.82 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 27.83 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 27.84 DILATATION ATRIAL | 4 0.04 27.88 DILATATION VENTRICULAR | 1 0.01 27.89 DIPLEGIA | 1 0.01 27.90 DIPLOPIA | 7 0.07 27.97 DISABILITY | 2 0.02 27.99 DISCOMFORT | 3 0.03 28.02 DISEASE PROGRESSION | 16 0.16 28.18 DISEASE RECURRENCE | 4 0.04 28.22 DISORIENTATION | 12 0.12 28.34 DISSEMINATED INTRAVASCULAR COAGULATION | 16 0.16 28.50 DISSEMINATED TUBERCULOSIS | 3 0.03 28.53 DISSOCIATION | 1 0.01 28.54 DISTURBANCE IN ATTENTION | 4 0.04 28.58 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 28.59 DIVERTICULAR FISTULA | 1 0.01 28.60 DIVERTICULAR PERFORATION | 1 0.01 28.61 DIVERTICULITIS | 3 0.03 28.64 DIVERTICULUM | 2 0.02 28.66 DIVERTICULUM INTESTINAL | 1 0.01 28.67 DIZZINESS | 65 0.65 29.32 DIZZINESS POSTURAL | 1 0.01 29.33 DRUG ABUSER | 10 0.10 29.43 DRUG ADMINISTRATION ERROR | 3 0.03 29.46 DRUG DEPENDENCE | 6 0.06 29.52 DRUG DISPENSING ERROR | 1 0.01 29.53 DRUG DOSE OMISSION | 4 0.04 29.57 DRUG EFFECT DECREASED | 2 0.02 29.59 DRUG ERUPTION | 4 0.04 29.63 DRUG EXPOSURE DURING PREGNANCY | 60 0.60 30.23 DRUG EXPOSURE VIA BREAST MILK | 3 0.03 30.26 DRUG HYPERSENSITIVITY | 17 0.17 30.43 DRUG INEFFECTIVE | 74 0.74 31.17 DRUG INTERACTION | 34 0.34 31.51 DRUG INTERACTION INHIBITION | 1 0.01 31.52 DRUG INTOLERANCE | 4 0.04 31.56 DRUG LEVEL BELOW THERAPEUTIC | 2 0.02 31.58 DRUG LEVEL DECREASED | 1 0.01 31.59 DRUG LEVEL FLUCTUATING | 1 0.01 31.60 DRUG LEVEL INCREASED | 6 0.06 31.66 DRUG PRESCRIBING ERROR | 1 0.01 31.67 DRUG SCREEN POSITIVE | 1 0.01 31.68 DRUG TOLERANCE | 1 0.01 31.69 DRUG TOXICITY | 14 0.14 31.83 DRUG WITHDRAWAL SYNDROME | 11 0.11 31.94 DRUG WITHDRAWAL SYNDROME NEONATAL | 3 0.03 31.97 DRY EYE | 6 0.06 32.03 DRY MOUTH | 7 0.07 32.10 DRY SKIN | 8 0.08 32.18 DRY THROAT | 1 0.01 32.19 DUODENAL STENOSIS | 1 0.01 32.20 DUODENAL ULCER | 4 0.04 32.24 DUODENAL ULCER HAEMORRHAGE | 1 0.01 32.25 DUODENITIS | 1 0.01 32.26 DYSARTHRIA | 4 0.04 32.30 DYSGEUSIA | 11 0.11 32.41 DYSGRAPHIA | 2 0.02 32.43 DYSKINESIA | 6 0.06 32.49 DYSLALIA | 2 0.02 32.51 DYSLIPIDAEMIA | 1 0.01 32.52 DYSMENORRHOEA | 1 0.01 32.53 DYSPEPSIA | 13 0.13 32.66 DYSPHAGIA | 13 0.13 32.79 DYSPHASIA | 1 0.01 32.80 DYSPHONIA | 8 0.08 32.88 DYSPNOEA | 79 0.79 33.67 DYSPNOEA AT REST | 1 0.01 33.68 DYSPNOEA EXERTIONAL | 4 0.04 33.72 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 33.73 DYSSTASIA | 7 0.07 33.80 DYSTONIA | 3 0.03 33.83 DYSURIA | 3 0.03 33.86 EAR DISCOMFORT | 2 0.02 33.88 EAR DISORDER | 1 0.01 33.89 EAR HAEMORRHAGE | 1 0.01 33.90 EAR INFECTION | 1 0.01 33.91 EAR PAIN | 2 0.02 33.93 EATING DISORDER | 2 0.02 33.95 ECCHYMOSIS | 1 0.01 33.96 ECTOPIC PREGNANCY | 2 0.02 33.98 ECZEMA | 1 0.01 33.99 EJECTION FRACTION DECREASED | 1 0.01 34.00 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 34.04 ELECTROCARDIOGRAM CHANGE | 2 0.02 34.06 ELECTROCARDIOGRAM Q WAVES | 1 0.01 34.07 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 4 0.04 34.11 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 34.16 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 34.17 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 34.18 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 34.19 ELECTROCARDIOGRAM ST-T SEGMENT DEPRES.. | 1 0.01 34.20 ELECTROCARDIOGRAM ST-T SEGMENT ELEVAT.. | 1 0.01 34.21 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 34.22 ELECTROCUTION | 1 0.01 34.23 ELECTROENCEPHALOGRAM ABNORMAL | 3 0.03 34.26 ELECTROMECHANICAL DISSOCIATION | 1 0.01 34.27 ELECTROPHORESIS ABNORMAL | 1 0.01 34.28 EMBOLISM | 5 0.05 34.33 EMOTIONAL DISORDER | 3 0.03 34.36 EMOTIONAL DISTRESS | 7 0.07 34.43 EMPHYSEMA | 1 0.01 34.44 EMPYEMA | 2 0.02 34.46 ENANTHEMA | 1 0.01 34.47 ENCEPHALITIS | 4 0.04 34.51 ENCEPHALITIS HERPES | 1 0.01 34.52 ENCEPHALITIS PROTOZOAL | 1 0.01 34.53 ENCEPHALOPATHY | 12 0.12 34.65 ENDOCARDITIS | 1 0.01 34.66 ENDOCRINE DISORDER | 1 0.01 34.67 ENDOMETRIOSIS | 4 0.04 34.71 ENTERITIS | 2 0.02 34.73 ENTEROBACTER BACTERAEMIA | 1 0.01 34.74 ENTEROCOCCAL INFECTION | 1 0.01 34.75 ENTEROCOLITIS HAEMORRHAGIC | 2 0.02 34.77 ENTEROCOLITIS INFECTIOUS | 1 0.01 34.78 ENURESIS | 1 0.01 34.79 EOSINOPHIL COUNT INCREASED | 5 0.05 34.84 EOSINOPHILIA | 3 0.03 34.87 EPIDERMOLYSIS | 2 0.02 34.89 EPIGASTRIC DISCOMFORT | 1 0.01 34.90 EPILEPTIC AURA | 1 0.01 34.91 EPISTAXIS | 15 0.15 35.06 ERB'S PALSY | 1 0.01 35.07 ERECTILE DYSFUNCTION | 1 0.01 35.08 ERECTION INCREASED | 2 0.02 35.10 EROSIVE OESOPHAGITIS | 2 0.02 35.12 ERUCTATION | 2 0.02 35.14 ERYSIPELAS | 1 0.01 35.15 ERYTHEMA | 23 0.23 35.38 ERYTHEMA MULTIFORME | 2 0.02 35.40 ERYTHEMA OF EYELID | 1 0.01 35.41 ERYTHROPOIESIS ABNORMAL | 1 0.01 35.42 ESCHERICHIA INFECTION | 2 0.02 35.44 EUPHORIC MOOD | 2 0.02 35.46 EUTHYROID SICK SYNDROME | 1 0.01 35.47 EXAGGERATED STARTLE RESPONSE | 1 0.01 35.48 EXCESSIVE EYE BLINKING | 1 0.01 35.49 EXCORIATION | 4 0.04 35.53 EXERCISE TOLERANCE DECREASED | 2 0.02 35.55 EXFOLIATIVE RASH | 1 0.01 35.56 EXOSTOSIS | 1 0.01 35.57 EXPIRED DRUG ADMINISTERED | 4 0.04 35.61 EXTENSOR PLANTAR RESPONSE | 1 0.01 35.62 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 1 0.01 35.63 EXTRAPYRAMIDAL DISORDER | 2 0.02 35.65 EXTRASYSTOLES | 1 0.01 35.66 EXTRAVASATION | 3 0.03 35.69 EXTREMITY CONTRACTURE | 1 0.01 35.70 EYE BURNS | 1 0.01 35.71 EYE DISCHARGE | 3 0.03 35.74 EYE DISORDER | 5 0.05 35.79 EYE HAEMORRHAGE | 2 0.02 35.81 EYE INFECTION | 2 0.02 35.83 EYE INFECTION TOXOPLASMAL | 2 0.02 35.85 EYE INJURY | 1 0.01 35.86 EYE IRRITATION | 3 0.03 35.89 EYE MOVEMENT DISORDER | 3 0.03 35.92 EYE OEDEMA | 1 0.01 35.93 EYE OPERATION | 1 0.01 35.94 EYE PAIN | 7 0.07 36.01 EYE SWELLING | 3 0.03 36.04 EYELID DISORDER | 1 0.01 36.05 EYELID OEDEMA | 4 0.04 36.09 EYELID PTOSIS | 3 0.03 36.12 FACE INJURY | 1 0.01 36.13 FACE OEDEMA | 7 0.07 36.20 FACIAL PALSY | 8 0.08 36.28 FAECAL INCONTINENCE | 4 0.04 36.32 FAECALOMA | 3 0.03 36.35 FAECES DISCOLOURED | 3 0.03 36.38 FAECES PALE | 1 0.01 36.39 FAILURE TO THRIVE | 3 0.03 36.42 FALL | 50 0.50 36.92 FAMILY STRESS | 1 0.01 36.93 FANCONI SYNDROME ACQUIRED | 2 0.02 36.95 FATIGUE | 69 0.69 37.64 FEAR | 1 0.01 37.65 FEBRILE NEUTROPENIA | 7 0.07 37.72 FEEDING DISORDER | 1 0.01 37.73 FEEDING DISORDER NEONATAL | 1 0.01 37.74 FEELING ABNORMAL | 21 0.21 37.95 FEELING COLD | 4 0.04 37.99 FEELING DRUNK | 4 0.04 38.03 FEELING HOT | 6 0.06 38.09 FEELING JITTERY | 4 0.04 38.13 FEMORAL NECK FRACTURE | 1 0.01 38.14 FEMUR FRACTURE | 6 0.06 38.20 FIBRIN D DIMER INCREASED | 1 0.01 38.21 FIBROADENOMA | 1 0.01 38.22 FIBROMA | 1 0.01 38.23 FIBROMYALGIA | 2 0.02 38.25 FIBROSIS | 1 0.01 38.26 FISTULA | 1 0.01 38.27 FLANK PAIN | 2 0.02 38.29 FLATULENCE | 9 0.09 38.38 FLUID RETENTION | 4 0.04 38.42 FLUSHING | 12 0.12 38.54 FOETAL CHROMOSOME ABNORMALITY | 1 0.01 38.55 FOETAL DISORDER | 1 0.01 38.56 FOETAL DISTRESS SYNDROME | 1 0.01 38.57 FOETAL GROWTH RETARDATION | 3 0.03 38.60 FOLLICULITIS | 2 0.02 38.62 FOOT DEFORMITY | 1 0.01 38.63 FOOT FRACTURE | 1 0.01 38.64 FOOT OPERATION | 1 0.01 38.65 FOREIGN BODY TRAUMA | 3 0.03 38.68 FORMICATION | 2 0.02 38.70 FRACTURE | 3 0.03 38.73 FREQUENT BOWEL MOVEMENTS | 1 0.01 38.74 FRUSTRATION | 3 0.03 38.77 FUNGAEMIA | 1 0.01 38.78 FUNGAL INFECTION | 4 0.04 38.82 FUNGAL SKIN INFECTION | 1 0.01 38.83 FUNGUS SPUTUM TEST POSITIVE | 1 0.01 38.84 FUNGUS URINE TEST POSITIVE | 1 0.01 38.85 FURUNCLE | 3 0.03 38.88 GAIT DISTURBANCE | 27 0.27 39.15 GALACTORRHOEA | 2 0.02 39.17 GALLBLADDER ABSCESS | 1 0.01 39.18 GALLBLADDER DISORDER | 6 0.06 39.24 GALLBLADDER PERFORATION | 1 0.01 39.25 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 21 0.21 39.46 GAMMOPATHY | 1 0.01 39.47 GANGRENE | 2 0.02 39.49 GASTRIC ANTRAL VASCULAR ECTASIA | 1 0.01 39.50 GASTRIC BANDING | 1 0.01 39.51 GASTRIC CANCER | 3 0.03 39.54 GASTRIC DISORDER | 3 0.03 39.57 GASTRIC HAEMORRHAGE | 4 0.04 39.61 GASTRIC MUCOSAL HYPERTROPHY | 2 0.02 39.63 GASTRIC MUCOSAL LESION | 1 0.01 39.64 GASTRIC PERFORATION | 1 0.01 39.65 GASTRIC ULCER | 4 0.04 39.69 GASTRIC ULCER HAEMORRHAGE | 4 0.04 39.73 GASTRIC ULCER PERFORATION | 2 0.02 39.75 GASTRITIS | 9 0.09 39.84 GASTRITIS EROSIVE | 1 0.01 39.85 GASTRITIS HAEMORRHAGIC | 1 0.01 39.86 GASTROENTERITIS | 5 0.05 39.91 GASTROINTESTINAL DISORDER | 11 0.11 40.02 GASTROINTESTINAL DISORDER CONGENITAL | 1 0.01 40.03 GASTROINTESTINAL FISTULA | 1 0.01 40.04 GASTROINTESTINAL HAEMORRHAGE | 15 0.15 40.19 GASTROINTESTINAL HYPOMOTILITY | 1 0.01 40.20 GASTROINTESTINAL INFECTION | 1 0.01 40.21 GASTROINTESTINAL INJURY | 2 0.02 40.23 GASTROINTESTINAL NECROSIS | 4 0.04 40.27 GASTROINTESTINAL NEOPLASM | 2 0.02 40.29 GASTROINTESTINAL STOMA COMPLICATION | 1 0.01 40.30 GASTROINTESTINAL STROMAL TUMOUR | 4 0.04 40.34 GASTROINTESTINAL TUBE INSERTION | 1 0.01 40.35 GASTROOESOPHAGEAL REFLUX DISEASE | 6 0.06 40.41 GAZE PALSY | 1 0.01 40.42 GENERAL PHYSICAL HEALTH DETERIORATION | 30 0.30 40.72 GENERAL SYMPTOM | 1 0.01 40.73 GENERALISED OEDEMA | 7 0.07 40.80 GENITAL DISORDER FEMALE | 1 0.01 40.81 GENITAL HAEMORRHAGE | 1 0.01 40.82 GENITAL INFECTION FUNGAL | 1 0.01 40.83 GENITAL INJURY | 1 0.01 40.84 GENITAL NEOPLASM MALIGNANT MALE | 2 0.02 40.86 GENITAL PAIN | 1 0.01 40.87 GENITAL ULCERATION | 1 0.01 40.88 GINGIVAL BLEEDING | 1 0.01 40.89 GINGIVAL DISORDER | 2 0.02 40.91 GINGIVAL INFECTION | 1 0.01 40.92 GINGIVAL PAIN | 4 0.04 40.96 GINGIVAL RECESSION | 1 0.01 40.97 GINGIVAL SWELLING | 1 0.01 40.98 GINGIVITIS | 2 0.02 41.00 GINGIVITIS ULCERATIVE | 1 0.01 41.01 GLASGOW COMA SCALE ABNORMAL | 2 0.02 41.03 GLAUCOMA | 4 0.04 41.07 GLIOBLASTOMA MULTIFORME | 1 0.01 41.08 GLIOSIS | 1 0.01 41.09 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 41.10 GLOMERULONEPHRITIS | 1 0.01 41.11 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 41.12 GLOSSITIS | 1 0.01 41.13 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 41.16 GOUT | 1 0.01 41.17 GRAFT VERSUS HOST DISEASE | 4 0.04 41.21 GRAND MAL CONVULSION | 9 0.09 41.30 GRANULOMA | 3 0.03 41.33 GROIN PAIN | 1 0.01 41.34 GROWTH RETARDATION | 1 0.01 41.35 GRUNTING | 1 0.01 41.36 GUILLAIN-BARRE SYNDROME | 1 0.01 41.37 GUN SHOT WOUND | 1 0.01 41.38 GYNAECOMASTIA | 1 0.01 41.39 HAEMANGIOMA OF LIVER | 1 0.01 41.40 HAEMARTHROSIS | 1 0.01 41.41 HAEMATEMESIS | 11 0.11 41.52 HAEMATOCHEZIA | 6 0.06 41.58 HAEMATOCRIT DECREASED | 11 0.11 41.69 HAEMATOCRIT INCREASED | 1 0.01 41.70 HAEMATOMA | 3 0.03 41.73 HAEMATURIA | 7 0.07 41.80 HAEMODIALYSIS | 6 0.06 41.86 HAEMODYNAMIC INSTABILITY | 1 0.01 41.87 HAEMOGLOBIN DECREASED | 36 0.36 42.23 HAEMOGLOBIN INCREASED | 3 0.03 42.26 HAEMOGLOBINOPATHY | 1 0.01 42.27 HAEMOLYSIS | 3 0.03 42.30 HAEMOLYTIC ANAEMIA | 3 0.03 42.33 HAEMOPTYSIS | 6 0.06 42.39 HAEMORRHAGE | 23 0.23 42.62 HAEMORRHAGE INTRACRANIAL | 5 0.05 42.67 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 42.68 HAEMORRHAGIC CYST | 1 0.01 42.69 HAEMORRHAGIC STROKE | 1 0.01 42.70 HAEMORRHAGIC TRANSFORMATION STROKE | 1 0.01 42.71 HAEMORRHOIDS | 4 0.04 42.75 HAEMOTHORAX | 1 0.01 42.76 HAIR GROWTH ABNORMAL | 1 0.01 42.77 HALLUCINATION | 16 0.16 42.93 HALLUCINATION, AUDITORY | 6 0.06 42.99 HALLUCINATION, VISUAL | 6 0.06 43.05 HALO VISION | 1 0.01 43.06 HAND DEFORMITY | 1 0.01 43.07 HANGOVER | 1 0.01 43.08 HAPTOGLOBIN DECREASED | 1 0.01 43.09 HEAD INJURY | 8 0.08 43.17 HEADACHE | 60 0.60 43.77 HEARING IMPAIRED | 2 0.02 43.79 HEART DISEASE CONGENITAL | 2 0.02 43.81 HEART INJURY | 3 0.03 43.84 HEART RATE ABNORMAL | 1 0.01 43.85 HEART RATE DECREASED | 3 0.03 43.88 HEART RATE INCREASED | 23 0.23 44.11 HEART RATE IRREGULAR | 3 0.03 44.14 HEAT RASH | 1 0.01 44.15 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 44.16 HEMIPARESIS | 5 0.05 44.21 HEMIPLEGIA | 2 0.02 44.23 HENOCH-SCHONLEIN PURPURA | 2 0.02 44.25 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 44.26 HEPATIC CIRRHOSIS | 4 0.04 44.30 HEPATIC CYST | 2 0.02 44.32 HEPATIC ENCEPHALOPATHY | 1 0.01 44.33 HEPATIC ENZYME ABNORMAL | 1 0.01 44.34 HEPATIC ENZYME INCREASED | 23 0.23 44.57 HEPATIC FAILURE | 7 0.07 44.64 HEPATIC FIBROSIS | 3 0.03 44.67 HEPATIC FUNCTION ABNORMAL | 15 0.15 44.82 HEPATIC LESION | 3 0.03 44.85 HEPATIC NECROSIS | 1 0.01 44.86 HEPATIC NEOPLASM MALIGNANT | 5 0.05 44.91 HEPATIC PAIN | 3 0.03 44.94 HEPATIC STEATOSIS | 4 0.04 44.98 HEPATITIS | 9 0.09 45.07 HEPATITIS C | 2 0.02 45.09 HEPATITIS C ANTIBODY | 1 0.01 45.10 HEPATITIS C POSITIVE | 2 0.02 45.12 HEPATITIS CHOLESTATIC | 6 0.06 45.18 HEPATITIS FULMINANT | 2 0.02 45.20 HEPATITIS VIRAL | 2 0.02 45.22 HEPATOBILIARY DISEASE | 2 0.02 45.24 HEPATOCELLULAR DAMAGE | 1 0.01 45.25 HEPATOJUGULAR REFLUX | 1 0.01 45.26 HEPATOMEGALY | 4 0.04 45.30 HEPATORENAL SYNDROME | 1 0.01 45.31 HEPATOSPLENOMEGALY | 2 0.02 45.33 HEPATOTOXICITY | 5 0.05 45.38 HERNIA REPAIR | 1 0.01 45.39 HERPES SIMPLEX | 3 0.03 45.42 HERPES ZOSTER | 9 0.09 45.51 HERPES ZOSTER DISSEMINATED | 1 0.01 45.52 HIATUS HERNIA | 1 0.01 45.53 HIGH DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 45.54 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 45.56 HIGH DENSITY LIPOPROTEIN INCREASED | 2 0.02 45.58 HILAR LYMPHADENOPATHY | 1 0.01 45.59 HIP ARTHROPLASTY | 2 0.02 45.61 HIP FRACTURE | 7 0.07 45.68 HISTOPLASMOSIS | 1 0.01 45.69 HIV TEST FALSE POSITIVE | 1 0.01 45.70 HODGKIN'S DISEASE | 1 0.01 45.71 HOMICIDAL IDEATION | 2 0.02 45.73 HOMICIDE | 1 0.01 45.74 HORMONE LEVEL ABNORMAL | 1 0.01 45.75 HOSPITALISATION | 5 0.05 45.80 HOSTILITY | 4 0.04 45.84 HOT FLUSH | 8 0.08 45.92 HUMERUS FRACTURE | 1 0.01 45.93 HYDROCEPHALUS | 2 0.02 45.95 HYDRONEPHROSIS | 6 0.06 46.01 HYDROURETER | 2 0.02 46.03 HYPERACUSIS | 2 0.02 46.05 HYPERAESTHESIA | 2 0.02 46.07 HYPERAMMONAEMIA | 1 0.01 46.08 HYPERBILIRUBINAEMIA | 4 0.04 46.12 HYPERCALCAEMIA | 5 0.05 46.17 HYPERCHLORHYDRIA | 2 0.02 46.19 HYPERCHOLESTEROLAEMIA | 3 0.03 46.22 HYPERCOAGULATION | 2 0.02 46.24 HYPERGLYCAEMIA | 3 0.03 46.27 HYPERHIDROSIS | 27 0.27 46.54 HYPERKALAEMIA | 14 0.14 46.68 HYPERLIPIDAEMIA | 2 0.02 46.70 HYPERNATRAEMIA | 1 0.01 46.71 HYPERPARATHYROIDISM | 1 0.01 46.72 HYPERREFLEXIA | 2 0.02 46.74 HYPERSENSITIVITY | 20 0.20 46.94 HYPERSOMNIA | 2 0.02 46.96 HYPERTENSION | 27 0.27 47.23 HYPERTENSIVE CRISIS | 1 0.01 47.24 HYPERTENSIVE EMERGENCY | 1 0.01 47.25 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 47.26 HYPERTHERMIA | 6 0.06 47.32 HYPERTHYROIDISM | 5 0.05 47.37 HYPERTONIA | 3 0.03 47.40 HYPERTRIGLYCERIDAEMIA | 4 0.04 47.44 HYPERVENTILATION | 3 0.03 47.47 HYPERVIGILANCE | 1 0.01 47.48 HYPOACUSIS | 2 0.02 47.50 HYPOAESTHESIA | 34 0.34 47.84 HYPOAESTHESIA FACIAL | 1 0.01 47.85 HYPOALBUMINAEMIA | 2 0.02 47.87 HYPOCALCAEMIA | 4 0.04 47.91 HYPOCHLORAEMIA | 1 0.01 47.92 HYPOCOAGULABLE STATE | 2 0.02 47.94 HYPOGEUSIA | 1 0.01 47.95 HYPOGLYCAEMIA | 10 0.10 48.05 HYPOGLYCAEMIC COMA | 2 0.02 48.07 HYPOGLYCAEMIC SEIZURE | 1 0.01 48.08 HYPOKALAEMIA | 16 0.16 48.24 HYPOMAGNESAEMIA | 4 0.04 48.28 HYPONATRAEMIA | 18 0.18 48.46 HYPOPERFUSION | 2 0.02 48.48 HYPOPHOSPHATAEMIA | 1 0.01 48.49 HYPOTENSION | 37 0.37 48.86 HYPOTHERMIA | 1 0.01 48.87 HYPOTHYROIDISM | 8 0.08 48.95 HYPOTONIA | 2 0.02 48.97 HYPOVOLAEMIA | 5 0.05 49.02 HYPOVOLAEMIC SHOCK | 1 0.01 49.03 HYPOXIA | 5 0.05 49.08 HYSTERECTOMY | 4 0.04 49.12 IATROGENIC INJURY | 1 0.01 49.13 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 49.15 ILEITIS | 1 0.01 49.16 ILEUS | 5 0.05 49.21 ILEUS PARALYTIC | 4 0.04 49.25 ILL-DEFINED DISORDER | 14 0.14 49.39 IMMOBILE | 5 0.05 49.44 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 49.45 IMMUNE SYSTEM DISORDER | 3 0.03 49.48 IMMUNODEFICIENCY | 1 0.01 49.49 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 49.50 IMMUNOSUPPRESSION | 1 0.01 49.51 IMPAIRED DRIVING ABILITY | 4 0.04 49.55 IMPAIRED HEALING | 4 0.04 49.59 IMPAIRED WORK ABILITY | 2 0.02 49.61 IMPLANTABLE DEFIBRILLATOR INSERTION | 2 0.02 49.63 IMPULSIVE BEHAVIOUR | 5 0.05 49.68 INADEQUATE ANALGESIA | 3 0.03 49.71 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 5 0.05 49.76 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 4 0.04 49.80 INCISION SITE COMPLICATION | 6 0.06 49.86 INCISION SITE HAEMORRHAGE | 8 0.08 49.94 INCISIONAL DRAINAGE | 1 0.01 49.95 INCISIONAL HERNIA | 1 0.01 49.96 INCOHERENT | 2 0.02 49.98 INCONTINENCE | 2 0.02 50.00 INCORRECT DOSE ADMINISTERED | 9 0.09 50.09 INCORRECT DRUG ADMINISTRATION DURATION | 2 0.02 50.11 INCORRECT ROUTE OF DRUG ADMINISTRATION | 2 0.02 50.13 INCREASED APPETITE | 2 0.02 50.15 INCREASED UPPER AIRWAY SECRETION | 2 0.02 50.17 INDURATION | 1 0.01 50.18 INFANT | 1 0.01 50.19 INFARCTION | 2 0.02 50.21 INFECTION | 24 0.24 50.45 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 50.46 INFECTIOUS MONONUCLEOSIS | 1 0.01 50.47 INFECTIVE EXACERBATION OF CHRONIC OBS.. | 1 0.01 50.48 INFLAMMATION | 6 0.06 50.54 INFLAMMATORY BOWEL DISEASE | 4 0.04 50.58 INFLUENZA | 8 0.08 50.66 INFLUENZA LIKE ILLNESS | 8 0.08 50.74 INFUSION RELATED REACTION | 9 0.09 50.83 INFUSION SITE DISCOLOURATION | 1 0.01 50.84 INFUSION SITE PAIN | 1 0.01 50.85 INFUSION SITE REACTION | 2 0.02 50.87 INGUINAL HERNIA, OBSTRUCTIVE | 1 0.01 50.88 INITIAL INSOMNIA | 1 0.01 50.89 INJECTION SITE ABSCESS | 1 0.01 50.90 INJECTION SITE BRUISING | 3 0.03 50.93 INJECTION SITE ERYTHEMA | 5 0.05 50.98 INJECTION SITE HAEMORRHAGE | 2 0.02 51.00 INJECTION SITE INDURATION | 1 0.01 51.01 INJECTION SITE INJURY | 1 0.01 51.02 INJECTION SITE IRRITATION | 2 0.02 51.04 INJECTION SITE MASS | 1 0.01 51.05 INJECTION SITE PAIN | 5 0.05 51.10 INJECTION SITE PHLEBITIS | 1 0.01 51.11 INJECTION SITE PRURITUS | 1 0.01 51.12 INJECTION SITE REACTION | 4 0.04 51.16 INJECTION SITE SWELLING | 1 0.01 51.17 INJECTION SITE URTICARIA | 1 0.01 51.18 INJURY | 12 0.12 51.30 INJURY ASPHYXIATION | 1 0.01 51.31 INSOMNIA | 38 0.38 51.69 INSPIRATORY CAPACITY DECREASED | 1 0.01 51.70 INTENTIONAL DRUG MISUSE | 12 0.12 51.82 INTENTIONAL OVERDOSE | 574 5.74 57.56 INTENTIONAL SELF-INJURY | 1 0.01 57.57 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 57.58 INTERNATIONAL NORMALISED RATIO INCREA.. | 18 0.18 57.76 INTERSTITIAL LUNG DISEASE | 12 0.12 57.88 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 57.89 INTERVERTEBRAL DISC DISORDER | 1 0.01 57.90 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 57.93 INTESTINAL GANGRENE | 1 0.01 57.94 INTESTINAL HAEMORRHAGE | 3 0.03 57.97 INTESTINAL ISCHAEMIA | 5 0.05 58.02 INTESTINAL OBSTRUCTION | 4 0.04 58.06 INTESTINAL PERFORATION | 5 0.05 58.11 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 58.12 INTRA-UTERINE DEATH | 4 0.04 58.16 INTRACARDIAC THROMBUS | 1 0.01 58.17 INTRACRANIAL ANEURYSM | 1 0.01 58.18 INTRACRANIAL HYPOTENSION | 1 0.01 58.19 INTRAOCULAR PRESSURE TEST ABNORMAL | 1 0.01 58.20 INTRAVENTRICULAR HAEMORRHAGE NEONATAL | 1 0.01 58.21 INTUBATION | 2 0.02 58.23 IRIS ADHESIONS | 1 0.01 58.24 IRIS HYPOPIGMENTATION | 1 0.01 58.25 IRITIS | 2 0.02 58.27 IRON DEFICIENCY | 1 0.01 58.28 IRON DEFICIENCY ANAEMIA | 4 0.04 58.32 IRRITABILITY | 15 0.15 58.47 IRRITABLE BOWEL SYNDROME | 3 0.03 58.50 ISCHAEMIA | 6 0.06 58.56 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 58.57 ISCHAEMIC ULCER | 1 0.01 58.58 JAUNDICE | 15 0.15 58.73 JAUNDICE CHOLESTATIC | 2 0.02 58.75 JAW DISORDER | 6 0.06 58.81 JOINT ARTHROPLASTY | 1 0.01 58.82 JOINT DISLOCATION | 2 0.02 58.84 JOINT INJURY | 3 0.03 58.87 JOINT LOCK | 1 0.01 58.88 JOINT RANGE OF MOTION DECREASED | 1 0.01 58.89 JOINT SPRAIN | 1 0.01 58.90 JOINT STIFFNESS | 5 0.05 58.95 JOINT SURGERY | 1 0.01 58.96 JOINT SWELLING | 6 0.06 59.02 JUGULAR VEIN DISTENSION | 1 0.01 59.03 JUGULAR VEIN THROMBOSIS | 1 0.01 59.04 KAPOSI'S SARCOMA | 1 0.01 59.05 KERATITIS BACTERIAL | 1 0.01 59.06 KERATOACANTHOMA | 1 0.01 59.07 KETOACIDOSIS | 1 0.01 59.08 KIDNEY ENLARGEMENT | 2 0.02 59.10 KIDNEY FIBROSIS | 1 0.01 59.11 KIDNEY INFECTION | 1 0.01 59.12 KIDNEY TRANSPLANT REJECTION | 3 0.03 59.15 KLEBSIELLA INFECTION | 3 0.03 59.18 KNEE ARTHROPLASTY | 2 0.02 59.20 KNEE OPERATION | 1 0.01 59.21 KORSAKOFF'S PSYCHOSIS ALCOHOLIC | 1 0.01 59.22 LABORATORY TEST ABNORMAL | 2 0.02 59.24 LABORATORY TEST INTERFERENCE | 1 0.01 59.25 LABYRINTHITIS | 3 0.03 59.28 LACERATION | 3 0.03 59.31 LACK OF SATIETY | 1 0.01 59.32 LACRIMATION INCREASED | 2 0.02 59.34 LACTIC ACIDOSIS | 4 0.04 59.38 LARGE FOR DATES BABY | 2 0.02 59.40 LARGE INTESTINAL ULCER | 3 0.03 59.43 LARGE INTESTINE CARCINOMA | 1 0.01 59.44 LARGE INTESTINE PERFORATION | 2 0.02 59.46 LARYNGEAL DISORDER | 1 0.01 59.47 LARYNGEAL OEDEMA | 5 0.05 59.52 LARYNGOSPASM | 1 0.01 59.53 LASER THERAPY | 1 0.01 59.54 LEARNING DISABILITY | 2 0.02 59.56 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCT.. | 1 0.01 59.57 LEFT VENTRICULAR FAILURE | 1 0.01 59.58 LEG AMPUTATION | 2 0.02 59.60 LEGIONELLA SEROLOGY POSITIVE | 1 0.01 59.61 LENS DISORDER | 1 0.01 59.62 LETHARGY | 14 0.14 59.76 LEUKAEMIA | 3 0.03 59.79 LEUKOCYTOCLASTIC VASCULITIS | 2 0.02 59.81 LEUKOCYTOSIS | 4 0.04 59.85 LEUKOENCEPHALOPATHY | 2 0.02 59.87 LEUKOPENIA | 13 0.13 60.00 LHERMITTE'S SIGN | 1 0.01 60.01 LIBIDO DECREASED | 2 0.02 60.03 LICHEN PLANUS | 1 0.01 60.04 LIFE EXPECTANCY SHORTENED | 1 0.01 60.05 LIFE SUPPORT | 1 0.01 60.06 LIGAMENT DISORDER | 1 0.01 60.07 LIMB DEFORMITY | 1 0.01 60.08 LIMB DISCOMFORT | 3 0.03 60.11 LIMB INJURY | 3 0.03 60.14 LIMB MALFORMATION | 1 0.01 60.15 LIMB TRAUMATIC AMPUTATION | 1 0.01 60.16 LIP DRY | 2 0.02 60.18 LIP SWELLING | 6 0.06 60.24 LIPASE INCREASED | 3 0.03 60.27 LIPIDS ABNORMAL | 1 0.01 60.28 LIPIDS INCREASED | 1 0.01 60.29 LIPODYSTROPHY ACQUIRED | 2 0.02 60.31 LISTERIOSIS | 1 0.01 60.32 LISTLESS | 2 0.02 60.34 LIVEDO RETICULARIS | 1 0.01 60.35 LIVER ABSCESS | 1 0.01 60.36 LIVER DISORDER | 16 0.16 60.52 LIVER FUNCTION TEST ABNORMAL | 9 0.09 60.61 LIVER INJURY | 1 0.01 60.62 LIVER TENDERNESS | 1 0.01 60.63 LIVER TRANSPLANT REJECTION | 1 0.01 60.64 LIVIDITY | 1 0.01 60.65 LOBAR PNEUMONIA | 1 0.01 60.66 LOCAL SWELLING | 4 0.04 60.70 LOCALISED INFECTION | 4 0.04 60.74 LOCKED-IN SYNDROME | 1 0.01 60.75 LOGORRHOEA | 1 0.01 60.76 LOOSE TOOTH | 1 0.01 60.77 LOSS OF CONSCIOUSNESS | 58 0.58 61.35 LOSS OF EMPLOYMENT | 2 0.02 61.37 LOW DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 61.38 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 61.40 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 61.42 LUNG ABSCESS | 1 0.01 61.43 LUNG ADENOCARCINOMA | 1 0.01 61.44 LUNG CONSOLIDATION | 2 0.02 61.46 LUNG DISORDER | 5 0.05 61.51 LUNG INFECTION | 1 0.01 61.52 LUNG INFILTRATION | 4 0.04 61.56 LUNG NEOPLASM | 2 0.02 61.58 LUNG NEOPLASM MALIGNANT | 9 0.09 61.67 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 1 0.01 61.68 LUPUS NEPHRITIS | 1 0.01 61.69 LUPUS-LIKE SYNDROME | 3 0.03 61.72 LYME DISEASE | 1 0.01 61.73 LYMPH NODE PAIN | 1 0.01 61.74 LYMPHADENECTOMY | 2 0.02 61.76 LYMPHADENOPATHY | 13 0.13 61.89 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 61.90 LYMPHOCYTE COUNT DECREASED | 8 0.08 61.98 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 61.99 LYMPHOCYTE STIMULATION TEST POSITIVE | 7 0.07 62.06 LYMPHOCYTIC INFILTRATION | 1 0.01 62.07 LYMPHOMA | 2 0.02 62.09 LYMPHOPENIA | 3 0.03 62.12 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 62.14 MACROCYTOSIS | 1 0.01 62.15 MACULAR DEGENERATION | 2 0.02 62.17 MACULAR OEDEMA | 3 0.03 62.20 MACULOPATHY | 2 0.02 62.22 MAJOR DEPRESSION | 1 0.01 62.23 MALABSORPTION | 1 0.01 62.24 MALAISE | 50 0.50 62.74 MALARIA | 1 0.01 62.75 MALIGNANT MELANOMA | 2 0.02 62.77 MALIGNANT MELANOMA IN SITU | 1 0.01 62.78 MALIGNANT NEOPLASM PROGRESSION | 11 0.11 62.89 MALIGNANT PLEURAL EFFUSION | 1 0.01 62.90 MALIGNANT RESPIRATORY TRACT NEOPLASM | 1 0.01 62.91 MALNUTRITION | 3 0.03 62.94 MANIA | 2 0.02 62.96 MARITAL PROBLEM | 1 0.01 62.97 MARROW HYPERPLASIA | 1 0.01 62.98 MASS | 3 0.03 63.01 MASTICATION DISORDER | 1 0.01 63.02 MEAN CELL HAEMOGLOBIN DECREASED | 1 0.01 63.03 MEAN CELL VOLUME DECREASED | 1 0.01 63.04 MEAN PLATELET VOLUME DECREASED | 2 0.02 63.06 MECHANICAL ILEUS | 1 0.01 63.07 MECONIUM IN AMNIOTIC FLUID | 1 0.01 63.08 MEDICAL DEVICE COMPLICATION | 4 0.04 63.12 MEDICATION ERROR | 8 0.08 63.20 MEDICATION RESIDUE | 2 0.02 63.22 MEGACOLON | 1 0.01 63.23 MELAENA | 5 0.05 63.28 MELANOCYTIC NAEVUS | 1 0.01 63.29 MEMORY IMPAIRMENT | 11 0.11 63.40 MENINGEAL NEOPLASM | 1 0.01 63.41 MENINGISM | 1 0.01 63.42 MENINGITIS | 2 0.02 63.44 MENINGITIS BACTERIAL | 1 0.01 63.45 MENORRHAGIA | 1 0.01 63.46 MENSTRUATION IRREGULAR | 3 0.03 63.49 MENTAL DISORDER | 6 0.06 63.55 MENTAL IMPAIRMENT | 8 0.08 63.63 MENTAL RETARDATION SEVERITY UNSPECIFIED | 2 0.02 63.65 MENTAL STATUS CHANGES | 14 0.14 63.79 METABOLIC ACIDOSIS | 11 0.11 63.90 METABOLIC DISORDER | 3 0.03 63.93 METABOLIC ENCEPHALOPATHY | 3 0.03 63.96 METABOLIC SYNDROME | 1 0.01 63.97 METASTASES TO ADRENALS | 2 0.02 63.99 METASTASES TO BONE | 2 0.02 64.01 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 64.04 METASTASES TO LIVER | 4 0.04 64.08 METASTASES TO LUNG | 4 0.04 64.12 METASTASES TO LYMPH NODES | 2 0.02 64.14 METASTASES TO PERITONEUM | 1 0.01 64.15 METASTASES TO SKIN | 1 0.01 64.16 METASTASES TO SMALL INTESTINE | 1 0.01 64.17 METASTASIS | 1 0.01 64.18 METASTATIC NEOPLASM | 1 0.01 64.19 METASTATIC RENAL CELL CARCINOMA | 2 0.02 64.21 METRORRHAGIA | 6 0.06 64.27 MICROCYTIC ANAEMIA | 3 0.03 64.30 MICROCYTOSIS | 1 0.01 64.31 MICTURITION DISORDER | 1 0.01 64.32 MICTURITION FREQUENCY DECREASED | 2 0.02 64.34 MICTURITION URGENCY | 1 0.01 64.35 MIDDLE EAR EFFUSION | 1 0.01 64.36 MIGRAINE | 5 0.05 64.41 MILIA | 1 0.01 64.42 MILK ALLERGY | 1 0.01 64.43 MITOCHONDRIAL CYTOPATHY | 2 0.02 64.45 MITOCHONDRIAL TOXICITY | 1 0.01 64.46 MITRAL VALVE DISEASE | 1 0.01 64.47 MITRAL VALVE INCOMPETENCE | 4 0.04 64.51 MOBILITY DECREASED | 5 0.05 64.56 MONOCYTE COUNT DECREASED | 1 0.01 64.57 MONOCYTE COUNT INCREASED | 1 0.01 64.58 MONOCYTE PERCENTAGE DECREASED | 1 0.01 64.59 MONOCYTE PERCENTAGE INCREASED | 1 0.01 64.60 MONOPARESIS | 1 0.01 64.61 MONOPLEGIA | 2 0.02 64.63 MOOD ALTERED | 5 0.05 64.68 MOOD SWINGS | 7 0.07 64.75 MORAXELLA INFECTION | 1 0.01 64.76 MOTOR DYSFUNCTION | 3 0.03 64.79 MOUTH HAEMORRHAGE | 3 0.03 64.82 MOUTH ULCERATION | 4 0.04 64.86 MOVEMENT DISORDER | 3 0.03 64.89 MUCOSAL EROSION | 1 0.01 64.90 MUCOSAL HAEMORRHAGE | 2 0.02 64.92 MUCOSAL INFLAMMATION | 6 0.06 64.98 MUCOUS STOOLS | 1 0.01 64.99 MULTI-ORGAN FAILURE | 22 0.22 65.21 MULTIPLE DRUG OVERDOSE | 4 0.04 65.25 MULTIPLE DRUG OVERDOSE INTENTIONAL | 7 0.07 65.32 MULTIPLE FRACTURES | 2 0.02 65.34 MULTIPLE INJURIES | 13 0.13 65.47 MULTIPLE MYELOMA | 3 0.03 65.50 MULTIPLE SCLEROSIS | 10 0.10 65.60 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 65.61 MUSCLE ATROPHY | 2 0.02 65.63 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 65.64 MUSCLE DISORDER | 6 0.06 65.70 MUSCLE ENZYME INCREASED | 1 0.01 65.71 MUSCLE INJURY | 1 0.01 65.72 MUSCLE RIGIDITY | 2 0.02 65.74 MUSCLE SPASMS | 22 0.22 65.96 MUSCLE SPASTICITY | 2 0.02 65.98 MUSCLE STRAIN | 1 0.01 65.99 MUSCLE TIGHTNESS | 2 0.02 66.01 MUSCLE TWITCHING | 8 0.08 66.09 MUSCULAR WEAKNESS | 12 0.12 66.21 MUSCULOSKELETAL CHEST PAIN | 1 0.01 66.22 MUSCULOSKELETAL DISCOMFORT | 1 0.01 66.23 MUSCULOSKELETAL DISORDER | 2 0.02 66.25 MUSCULOSKELETAL PAIN | 9 0.09 66.34 MUSCULOSKELETAL STIFFNESS | 13 0.13 66.47 MYALGIA | 36 0.36 66.83 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 66.84 MYCOSIS FUNGOIDES | 1 0.01 66.85 MYDRIASIS | 8 0.08 66.93 MYELODYSPLASTIC SYNDROME | 5 0.05 66.98 MYELOPATHY | 1 0.01 66.99 MYOCARDIAL INFARCTION | 50 0.50 67.49 MYOCARDIAL ISCHAEMIA | 8 0.08 67.57 MYOCARDITIS | 3 0.03 67.60 MYOCLONUS | 6 0.06 67.66 MYOGLOBIN BLOOD INCREASED | 3 0.03 67.69 MYOGLOBIN URINE PRESENT | 1 0.01 67.70 MYOGLOBINAEMIA | 1 0.01 67.71 MYOMECTOMY | 1 0.01 67.72 MYOPATHY | 3 0.03 67.75 MYOPATHY STEROID | 1 0.01 67.76 MYOPIA | 1 0.01 67.77 NAIL BED BLEEDING | 1 0.01 67.78 NASAL DISCOMFORT | 2 0.02 67.80 NASAL DISORDER | 1 0.01 67.81 NASAL MUCOSAL DISORDER | 1 0.01 67.82 NASOPHARYNGEAL DISORDER | 1 0.01 67.83 NASOPHARYNGITIS | 6 0.06 67.89 NAUSEA | 117 1.17 69.06 NECK INJURY | 1 0.01 69.07 NECK MASS | 1 0.01 69.08 NECK PAIN | 5 0.05 69.13 NECROSIS | 2 0.02 69.15 NECROTISING COLITIS | 1 0.01 69.16 NECROTISING FASCIITIS | 2 0.02 69.18 NEGATIVE THOUGHTS | 1 0.01 69.19 NEGATIVISM | 1 0.01 69.20 NEONATAL ASPHYXIA | 4 0.04 69.24 NEONATAL HEPATOMEGALY | 1 0.01 69.25 NEONATAL HYPOTENSION | 1 0.01 69.26 NEOPLASM | 3 0.03 69.29 NEOPLASM MALIGNANT | 5 0.05 69.34 NEOPLASM PROGRESSION | 3 0.03 69.37 NEOPLASM RECURRENCE | 1 0.01 69.38 NEPHRECTOMY | 1 0.01 69.39 NEPHRITIS | 3 0.03 69.42 NEPHRITIS INTERSTITIAL | 1 0.01 69.43 NEPHROGENIC ANAEMIA | 1 0.01 69.44 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 69.45 NEPHROGENIC FIBROSING DERMOPATHY | 2 0.02 69.47 NEPHROLITHIASIS | 6 0.06 69.53 NEPHROPATHY | 1 0.01 69.54 NEPHROPATHY TOXIC | 1 0.01 69.55 NEPHROTIC SYNDROME | 6 0.06 69.61 NERVE COMPRESSION | 2 0.02 69.63 NERVE INJURY | 2 0.02 69.65 NERVOUS SYSTEM DISORDER | 8 0.08 69.73 NERVOUSNESS | 12 0.12 69.85 NEURALGIA | 2 0.02 69.87 NEURITIS | 2 0.02 69.89 NEURODERMATITIS | 1 0.01 69.90 NEUROFIBROMATOSIS | 1 0.01 69.91 NEUROLEPTIC MALIGNANT SYNDROME | 10 0.10 70.01 NEUROLOGICAL SYMPTOM | 2 0.02 70.03 NEUROPATHY | 3 0.03 70.06 NEUROPATHY PERIPHERAL | 6 0.06 70.12 NEUROPSYCHOLOGICAL TEST ABNORMAL | 1 0.01 70.13 NEUROTOXICITY | 3 0.03 70.16 NEUTROPENIA | 27 0.27 70.43 NEUTROPENIC SEPSIS | 1 0.01 70.44 NEUTROPHIL COUNT ABNORMAL | 2 0.02 70.46 NEUTROPHIL COUNT DECREASED | 3 0.03 70.49 NEUTROPHIL COUNT INCREASED | 2 0.02 70.51 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.52 NEUTROPHILIA | 1 0.01 70.53 NIGHT BLINDNESS | 1 0.01 70.54 NIGHT SWEATS | 3 0.03 70.57 NIGHTMARE | 4 0.04 70.61 NO ADVERSE DRUG EFFECT | 17 0.17 70.78 NO ADVERSE EFFECT | 3 0.03 70.81 NO REACTION ON PREVIOUS EXPOSURE TO D.. | 1 0.01 70.82 NO THERAPEUTIC RESPONSE | 10 0.10 70.92 NOCARDIOSIS | 1 0.01 70.93 NOCTURIA | 1 0.01 70.94 NODAL RHYTHM | 1 0.01 70.95 NON-CARDIAC CHEST PAIN | 1 0.01 70.96 NON-HODGKIN'S LYMPHOMA | 2 0.02 70.98 NORMOCHROMIC NORMOCYTIC ANAEMIA | 3 0.03 71.01 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 71.03 OBESITY | 1 0.01 71.04 OBLITERATIVE BRONCHIOLITIS | 1 0.01 71.05 OBSESSIVE THOUGHTS | 1 0.01 71.06 OBSTRUCTION | 1 0.01 71.07 OBSTRUCTIVE UROPATHY | 1 0.01 71.08 OCCULT BLOOD | 1 0.01 71.09 OCCULT BLOOD POSITIVE | 3 0.03 71.12 OCULAR ICTERUS | 2 0.02 71.14 OCULOGYRATION | 1 0.01 71.15 ODYNOPHAGIA | 2 0.02 71.17 OEDEMA | 6 0.06 71.23 OEDEMA GENITAL | 2 0.02 71.25 OEDEMA MOUTH | 1 0.01 71.26 OEDEMA PERIPHERAL | 36 0.36 71.62 OESOPHAGEAL CANDIDIASIS | 2 0.02 71.64 OESOPHAGEAL CARCINOMA | 1 0.01 71.65 OESOPHAGEAL DISORDER | 1 0.01 71.66 OESOPHAGEAL OBSTRUCTION | 2 0.02 71.68 OESOPHAGEAL OEDEMA | 1 0.01 71.69 OESOPHAGEAL ULCER | 1 0.01 71.70 OESOPHAGITIS | 3 0.03 71.73 OESOPHAGITIS ULCERATIVE | 1 0.01 71.74 OESOPHAGOGASTRODUODENOSCOPY | 1 0.01 71.75 OFF LABEL USE | 1 0.01 71.76 OLIGOHYDRAMNIOS | 5 0.05 71.81 OLIGURIA | 2 0.02 71.83 ONYCHOMYCOSIS | 1 0.01 71.84 OPEN WOUND | 1 0.01 71.85 OPERATIVE HAEMORRHAGE | 1 0.01 71.86 OPISTHOTONUS | 1 0.01 71.87 OPTIC ISCHAEMIC NEUROPATHY | 4 0.04 71.91 OPTIC NERVE DISORDER | 2 0.02 71.93 OPTIC NERVE SHEATH HAEMORRHAGE | 1 0.01 71.94 OPTIC NEURITIS | 2 0.02 71.96 ORAL CANDIDIASIS | 4 0.04 72.00 ORAL CAVITY FISTULA | 1 0.01 72.01 ORAL DISCOMFORT | 2 0.02 72.03 ORAL INFECTION | 1 0.01 72.04 ORAL INTAKE REDUCED | 7 0.07 72.11 ORAL MUCOSAL DISORDER | 2 0.02 72.13 ORAL MUCOSAL EXFOLIATION | 1 0.01 72.14 ORAL PAIN | 5 0.05 72.19 ORAL SOFT TISSUE DISORDER | 1 0.01 72.20 ORAL TORUS | 1 0.01 72.21 ORTHOSTATIC HYPOTENSION | 3 0.03 72.24 OSTEOARTHRITIS | 3 0.03 72.27 OSTEOLYSIS | 1 0.01 72.28 OSTEOMYELITIS | 4 0.04 72.32 OSTEOMYELITIS BACTERIAL | 1 0.01 72.33 OSTEONECROSIS | 21 0.21 72.54 OSTEOPENIA | 1 0.01 72.55 OSTEOPOROSIS | 2 0.02 72.57 OTOSCLEROSIS | 1 0.01 72.58 OVARIAN CANCER | 1 0.01 72.59 OVARIAN CANCER METASTATIC | 2 0.02 72.61 OVARIAN CANCER RECURRENT | 2 0.02 72.63 OVARIAN CYST | 3 0.03 72.66 OVERDOSE | 29 0.29 72.95 OXYGEN SATURATION DECREASED | 16 0.16 73.11 PACKED RED BLOOD CELL TRANSFUSION | 1 0.01 73.12 PAIN | 50 0.50 73.62 PAIN IN EXTREMITY | 31 0.31 73.93 PAIN IN JAW | 6 0.06 73.99 PAIN MANAGEMENT | 1 0.01 74.00 PAIN OF SKIN | 1 0.01 74.01 PAINFUL RESPIRATION | 1 0.01 74.02 PALLANAESTHESIA | 1 0.01 74.03 PALLOR | 9 0.09 74.12 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 3 0.03 74.15 PALPITATIONS | 10 0.10 74.25 PANCREATIC CARCINOMA | 2 0.02 74.27 PANCREATIC CARCINOMA METASTATIC | 1 0.01 74.28 PANCREATIC ENZYMES INCREASED | 1 0.01 74.29 PANCREATIC NECROSIS | 1 0.01 74.30 PANCREATITIS | 10 0.10 74.40 PANCREATITIS ACUTE | 3 0.03 74.43 PANCREATOLITHIASIS | 1 0.01 74.44 PANCYTOPENIA | 16 0.16 74.60 PANIC ATTACK | 6 0.06 74.66 PANIC DISORDER | 2 0.02 74.68 PANIC REACTION | 1 0.01 74.69 PAPILLARY THYROID CANCER | 1 0.01 74.70 PAPILLOEDEMA | 1 0.01 74.71 PAPILLOMA VIRAL INFECTION | 1 0.01 74.72 PARAESTHESIA | 23 0.23 74.95 PARAESTHESIA ORAL | 1 0.01 74.96 PARALYSIS | 4 0.04 75.00 PARANOIA | 7 0.07 75.07 PARAPARESIS | 1 0.01 75.08 PARATHYROID DISORDER | 1 0.01 75.09 PARENTERAL NUTRITION | 1 0.01 75.10 PARESIS | 1 0.01 75.11 PARESIS CRANIAL NERVE | 1 0.01 75.12 PARKINSON'S DISEASE | 1 0.01 75.13 PARKINSONIAN GAIT | 1 0.01 75.14 PARKINSONISM | 1 0.01 75.15 PAROTITIS | 1 0.01 75.16 PAROVARIAN CYST | 1 0.01 75.17 PARTIAL SEIZURES | 1 0.01 75.18 PARVOVIRUS B19 SEROLOGY POSITIVE | 1 0.01 75.19 PATELLA FRACTURE | 2 0.02 75.21 PATHOGEN RESISTANCE | 1 0.01 75.22 PCO2 DECREASED | 2 0.02 75.24 PCO2 INCREASED | 1 0.01 75.25 PELVIC ABSCESS | 1 0.01 75.26 PELVIC FRACTURE | 2 0.02 75.28 PELVIC MASS | 2 0.02 75.30 PELVIC PAIN | 3 0.03 75.33 PEMPHIGOID | 5 0.05 75.38 PEPTIC ULCER | 2 0.02 75.40 PERFORMANCE STATUS DECREASED | 2 0.02 75.42 PERIANAL ABSCESS | 2 0.02 75.44 PERICARDIAL DISEASE | 1 0.01 75.45 PERICARDIAL EFFUSION | 6 0.06 75.51 PERICARDIAL HAEMORRHAGE | 3 0.03 75.54 PERICARDITIS | 1 0.01 75.55 PERIODONTITIS | 2 0.02 75.57 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 75.58 PERIPHERAL COLDNESS | 5 0.05 75.63 PERIPHERAL ISCHAEMIA | 1 0.01 75.64 PERIPHERAL SENSORIMOTOR NEUROPATHY | 1 0.01 75.65 PERIPHERAL VASCULAR DISORDER | 2 0.02 75.67 PERIRECTAL ABSCESS | 1 0.01 75.68 PERITONEAL CYST | 1 0.01 75.69 PERITONEAL DIALYSIS | 2 0.02 75.71 PERITONEAL HAEMORRHAGE | 1 0.01 75.72 PERITONITIS | 6 0.06 75.78 PERNICIOUS ANAEMIA | 1 0.01 75.79 PERONEAL MUSCULAR ATROPHY | 1 0.01 75.80 PERONEAL NERVE PALSY | 2 0.02 75.82 PERSECUTORY DELUSION | 3 0.03 75.85 PERSONALITY CHANGE | 5 0.05 75.90 PERSONALITY DISORDER | 1 0.01 75.91 PETECHIAE | 2 0.02 75.93 PETIT MAL EPILEPSY | 2 0.02 75.95 PH URINE INCREASED | 1 0.01 75.96 PHARMACEUTICAL PRODUCT COMPLAINT | 37 0.37 76.33 PHARYNGEAL OEDEMA | 2 0.02 76.35 PHARYNGITIS | 2 0.02 76.37 PHARYNGITIS STREPTOCOCCAL | 1 0.01 76.38 PHARYNGOLARYNGEAL PAIN | 5 0.05 76.43 PHENYLALANINE SCREEN POSITIVE | 1 0.01 76.44 PHOBIA | 1 0.01 76.45 PHONOLOGICAL DISORDER | 1 0.01 76.46 PHOTODERMATOSIS | 1 0.01 76.47 PHOTOPHOBIA | 6 0.06 76.53 PHOTOPSIA | 1 0.01 76.54 PHOTOSENSITIVITY REACTION | 4 0.04 76.58 PHYSICAL DISABILITY | 1 0.01 76.59 PINEALOBLASTOMA | 1 0.01 76.60 PITTING OEDEMA | 1 0.01 76.61 PITUITARY TUMOUR BENIGN | 1 0.01 76.62 PLACENTA PRAEVIA | 1 0.01 76.63 PLACENTAL DISORDER | 2 0.02 76.65 PLASTIC SURGERY | 1 0.01 76.66 PLATELET COUNT ABNORMAL | 1 0.01 76.67 PLATELET COUNT DECREASED | 34 0.34 77.01 PLATELET COUNT INCREASED | 6 0.06 77.07 PLEURAL EFFUSION | 24 0.24 77.31 PLEURISY | 3 0.03 77.34 PLEURITIC PAIN | 3 0.03 77.37 PNEUMATOSIS INTESTINALIS | 1 0.01 77.38 PNEUMOBILIA | 1 0.01 77.39 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 77.40 PNEUMOCYSTIS JIROVECI PNEUMONIA | 9 0.09 77.49 PNEUMOMEDIASTINUM | 1 0.01 77.50 PNEUMONIA | 53 0.53 78.03 PNEUMONIA ASPIRATION | 6 0.06 78.09 PNEUMONIA BACTERIAL | 1 0.01 78.10 PNEUMONIA FUNGAL | 1 0.01 78.11 PNEUMONIA PNEUMOCOCCAL | 1 0.01 78.12 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.13 PNEUMONITIS | 3 0.03 78.16 PNEUMONITIS CRYPTOCOCCAL | 1 0.01 78.17 PNEUMOTHORAX | 4 0.04 78.21 PO2 DECREASED | 1 0.01 78.22 PO2 INCREASED | 1 0.01 78.23 POISONING | 2 0.02 78.25 POISONING DELIBERATE | 1 0.01 78.26 POLLAKIURIA | 6 0.06 78.32 POLYARTHRITIS | 1 0.01 78.33 POLYDACTYLY | 2 0.02 78.35 POLYMYALGIA RHEUMATICA | 1 0.01 78.36 POLYMYOSITIS | 1 0.01 78.37 POLYP | 1 0.01 78.38 POLYP COLORECTAL | 1 0.01 78.39 POLYPECTOMY | 1 0.01 78.40 POOR PERSONAL HYGIENE | 1 0.01 78.41 POOR QUALITY DRUG ADMINISTERED | 2 0.02 78.43 POOR QUALITY SLEEP | 2 0.02 78.45 PORTAL HYPERTENSION | 1 0.01 78.46 PORTAL VEIN THROMBOSIS | 1 0.01 78.47 POST HERPETIC NEURALGIA | 1 0.01 78.48 POST PROCEDURAL COMPLICATION | 5 0.05 78.53 POST PROCEDURAL HAEMATOMA | 1 0.01 78.54 POST PROCEDURAL HAEMORRHAGE | 6 0.06 78.60 POST PROCEDURAL INFECTION | 1 0.01 78.61 POST PROCEDURAL PULMONARY EMBOLISM | 1 0.01 78.62 POST-TRAUMATIC STRESS DISORDER | 1 0.01 78.63 POSTICTAL STATE | 1 0.01 78.64 POSTNASAL DRIP | 1 0.01 78.65 POSTOPERATIVE WOUND INFECTION | 1 0.01 78.66 POSTURAL ORTHOSTATIC TACHYCARDIA SYND.. | 1 0.01 78.67 PRE-ECLAMPSIA | 2 0.02 78.69 PREGNANCY | 12 0.12 78.81 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 78.82 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 78.83 PREMATURE BABY | 5 0.05 78.88 PREMATURE CLOSURE OF CRANIAL SUTURES | 1 0.01 78.89 PREMATURE LABOUR | 4 0.04 78.93 PREMATURE MENOPAUSE | 1 0.01 78.94 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 78.95 PRESCRIBED OVERDOSE | 2 0.02 78.97 PRESYNCOPE | 3 0.03 79.00 PRIMARY SEQUESTRUM | 1 0.01 79.01 PROCEDURAL COMPLICATION | 6 0.06 79.07 PROCEDURAL HYPERTENSION | 1 0.01 79.08 PROCEDURAL PAIN | 2 0.02 79.10 PRODUCTIVE COUGH | 4 0.04 79.14 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 79.15 PROLONGED LABOUR | 1 0.01 79.16 PROSTATE CANCER | 3 0.03 79.19 PROSTATE EXAMINATION ABNORMAL | 1 0.01 79.20 PROSTATE INFECTION | 1 0.01 79.21 PROSTATITIS | 2 0.02 79.23 PROSTRATION | 1 0.01 79.24 PROTEIN ALBUMIN RATIO | 1 0.01 79.25 PROTEIN TOTAL DECREASED | 3 0.03 79.28 PROTEIN TOTAL INCREASED | 2 0.02 79.30 PROTEIN URINE | 1 0.01 79.31 PROTEIN URINE PRESENT | 1 0.01 79.32 PROTEINURIA | 6 0.06 79.38 PROTEUS INFECTION | 1 0.01 79.39 PROTHROMBIN TIME PROLONGED | 4 0.04 79.43 PROTHROMBIN TIME SHORTENED | 3 0.03 79.46 PRURIGO | 1 0.01 79.47 PRURITUS | 27 0.27 79.74 PRURITUS GENERALISED | 2 0.02 79.76 PRURITUS GENITAL | 1 0.01 79.77 PSEUDO-BARTTER SYNDROME | 1 0.01 79.78 PSEUDOMONAS INFECTION | 3 0.03 79.81 PSORIASIS | 3 0.03 79.84 PSORIATIC ARTHROPATHY | 1 0.01 79.85 PSYCHOMOTOR HYPERACTIVITY | 5 0.05 79.90 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 79.91 PSYCHOTIC DISORDER | 10 0.10 80.01 PULMONARY ARTERIAL PRESSURE INCREASED | 6 0.06 80.07 PULMONARY ARTERY THROMBOSIS | 1 0.01 80.08 PULMONARY CAVITATION | 1 0.01 80.09 PULMONARY CONGESTION | 5 0.05 80.14 PULMONARY EMBOLISM | 28 0.28 80.42 PULMONARY FIBROSIS | 5 0.05 80.47 PULMONARY FUNCTION TEST DECREASED | 1 0.01 80.48 PULMONARY HAEMATOMA | 1 0.01 80.49 PULMONARY HAEMORRHAGE | 1 0.01 80.50 PULMONARY HYPERTENSION | 6 0.06 80.56 PULMONARY INFARCTION | 1 0.01 80.57 PULMONARY MASS | 3 0.03 80.60 PULMONARY OEDEMA | 10 0.10 80.70 PULMONARY TUBERCULOSIS | 3 0.03 80.73 PULMONARY VALVE INCOMPETENCE | 2 0.02 80.75 PULMONARY VASCULAR DISORDER | 2 0.02 80.77 PULMONARY VASCULITIS | 1 0.01 80.78 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 80.79 PULSE ABSENT | 2 0.02 80.81 PULSE PRESSURE DECREASED | 1 0.01 80.82 PUPIL FIXED | 3 0.03 80.85 PUPILS UNEQUAL | 1 0.01 80.86 PURPURA | 7 0.07 80.93 PURULENCE | 2 0.02 80.95 PUS IN STOOL | 1 0.01 80.96 PUTAMEN HAEMORRHAGE | 1 0.01 80.97 PYELECTASIA | 1 0.01 80.98 PYELONEPHRITIS | 3 0.03 81.01 PYLOROPLASTY | 1 0.01 81.02 PYREXIA | 87 0.87 81.89 PYROGLUTAMATE INCREASED | 1 0.01 81.90 PYURIA | 1 0.01 81.91 RADIATION OESOPHAGITIS | 1 0.01 81.92 RADICULAR PAIN | 1 0.01 81.93 RADIOTHERAPY | 1 0.01 81.94 RALES | 4 0.04 81.98 RAPID EYE MOVEMENTS SLEEP ABNORMAL | 1 0.01 81.99 RASH | 43 0.43 82.42 RASH ERYTHEMATOUS | 7 0.07 82.49 RASH GENERALISED | 12 0.12 82.61 RASH MACULAR | 5 0.05 82.66 RASH MACULO-PAPULAR | 1 0.01 82.67 RASH PAPULAR | 3 0.03 82.70 RASH PRURITIC | 5 0.05 82.75 RASH PUSTULAR | 1 0.01 82.76 RASH SCARLATINIFORM | 2 0.02 82.78 REACTION TO DRUG EXCIPIENTS | 1 0.01 82.79 RECTAL ABSCESS | 1 0.01 82.80 RECTAL CANCER | 3 0.03 82.83 RECTAL FISSURE | 1 0.01 82.84 RECTAL HAEMORRHAGE | 11 0.11 82.95 RECTAL ULCER | 1 0.01 82.96 RECURRENT CANCER | 1 0.01 82.97 RED BLOOD CELL ABNORMALITY | 1 0.01 82.98 RED BLOOD CELL COUNT DECREASED | 10 0.10 83.08 RED BLOOD CELL SEDIMENTATION RATE INC.. | 4 0.04 83.12 RED CELL DISTRIBUTION WIDTH INCREASED | 2 0.02 83.14 REFLUX OESOPHAGITIS | 1 0.01 83.15 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 83.17 REFUSAL OF TREATMENT BY RELATIVE | 1 0.01 83.18 REGRESSIVE BEHAVIOUR | 1 0.01 83.19 RENAL AND PANCREAS TRANSPLANT REJECTION | 1 0.01 83.20 RENAL APLASIA | 1 0.01 83.21 RENAL ARTERY OCCLUSION | 1 0.01 83.22 RENAL ARTERY STENOSIS | 1 0.01 83.23 RENAL ARTERY STENT PLACEMENT | 1 0.01 83.24 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 3 0.03 83.27 RENAL CYST | 4 0.04 83.31 RENAL DISORDER | 6 0.06 83.37 RENAL FAILURE | 31 0.31 83.68 RENAL FAILURE ACUTE | 54 0.54 84.22 RENAL FAILURE CHRONIC | 5 0.05 84.27 RENAL HAEMORRHAGE | 1 0.01 84.28 RENAL IMPAIRMENT | 10 0.10 84.38 RENAL IMPAIRMENT NEONATAL | 1 0.01 84.39 RENAL INFARCT | 1 0.01 84.40 RENAL PAIN | 2 0.02 84.42 RENAL TRANSPLANT | 2 0.02 84.44 RENAL TUBULAR ACIDOSIS | 1 0.01 84.45 RENAL TUBULAR DISORDER | 1 0.01 84.46 RENAL TUBULAR NECROSIS | 4 0.04 84.50 RENIN DECREASED | 1 0.01 84.51 RENIN INCREASED | 2 0.02 84.53 REPERFUSION INJURY | 1 0.01 84.54 REPRODUCTIVE TRACT DISORDER | 1 0.01 84.55 RESORPTION BONE INCREASED | 2 0.02 84.57 RESPIRATION ABNORMAL | 1 0.01 84.58 RESPIRATORY ALKALOSIS | 1 0.01 84.59 RESPIRATORY ARREST | 13 0.13 84.72 RESPIRATORY DEPRESSION | 1 0.01 84.73 RESPIRATORY DISORDER | 4 0.04 84.77 RESPIRATORY DISORDER NEONATAL | 3 0.03 84.80 RESPIRATORY DISTRESS | 9 0.09 84.89 RESPIRATORY FAILURE | 20 0.20 85.09 RESPIRATORY RATE DECREASED | 2 0.02 85.11 RESPIRATORY RATE INCREASED | 4 0.04 85.15 RESPIRATORY TRACT HAEMORRHAGE | 1 0.01 85.16 RESPIRATORY TRACT INFECTION | 1 0.01 85.17 RESTLESS LEGS SYNDROME | 2 0.02 85.19 RESTLESSNESS | 11 0.11 85.30 RETCHING | 5 0.05 85.35 RETICULOCYTE COUNT DECREASED | 2 0.02 85.37 RETINAL ARTERY OCCLUSION | 3 0.03 85.40 RETINAL DETACHMENT | 4 0.04 85.44 RETINAL DISORDER | 2 0.02 85.46 RETINAL HAEMORRHAGE | 5 0.05 85.51 RETINAL ISCHAEMIA | 1 0.01 85.52 RETINAL OPERATION | 1 0.01 85.53 RETINAL PIGMENT EPITHELIOPATHY | 1 0.01 85.54 RETINAL TEAR | 1 0.01 85.55 RETINAL VEIN THROMBOSIS | 1 0.01 85.56 RETINOPATHY | 1 0.01 85.57 RETROPERITONEAL FIBROSIS | 1 0.01 85.58 RETROPERITONEAL HAEMATOMA | 2 0.02 85.60 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 4 0.04 85.64 RHABDOMYOLYSIS | 18 0.18 85.82 RHEUMATOID ARTHRITIS | 5 0.05 85.87 RHEUMATOID LUNG | 1 0.01 85.88 RHINITIS ALLERGIC | 1 0.01 85.89 RHINORRHOEA | 2 0.02 85.91 RHONCHI | 1 0.01 85.92 RIB FRACTURE | 1 0.01 85.93 ROAD TRAFFIC ACCIDENT | 4 0.04 85.97 ROTATOR CUFF REPAIR | 1 0.01 85.98 SALIVARY HYPERSECRETION | 2 0.02 86.00 SALMONELLOSIS | 1 0.01 86.01 SARCOIDOSIS | 2 0.02 86.03 SCAB | 1 0.01 86.04 SCAR | 2 0.02 86.06 SCHIZOAFFECTIVE DISORDER | 2 0.02 86.08 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 86.09 SCHIZOPHRENIFORM DISORDER | 1 0.01 86.10 SCIATICA | 1 0.01 86.11 SCLERODERMA | 1 0.01 86.12 SCROTAL OEDEMA | 1 0.01 86.13 SCROTAL SWELLING | 1 0.01 86.14 SEBORRHOEA | 1 0.01 86.15 SECRETION DISCHARGE | 1 0.01 86.16 SEDATION | 6 0.06 86.22 SELF INJURIOUS BEHAVIOUR | 2 0.02 86.24 SELF-INDUCED VOMITING | 2 0.02 86.26 SELF-MEDICATION | 1 0.01 86.27 SENSATION OF FOREIGN BODY | 2 0.02 86.29 SENSATION OF HEAVINESS | 4 0.04 86.33 SENSE OF OPPRESSION | 1 0.01 86.34 SENSITIVITY OF TEETH | 1 0.01 86.35 SENSORY DISTURBANCE | 5 0.05 86.40 SENSORY LOSS | 2 0.02 86.42 SEPSIS | 26 0.26 86.68 SEPSIS SYNDROME | 1 0.01 86.69 SEPTIC SHOCK | 6 0.06 86.75 SEQUESTRECTOMY | 1 0.01 86.76 SEROCONVERSION TEST POSITIVE | 1 0.01 86.77 SEROTONIN SYNDROME | 4 0.04 86.81 SERUM FERRITIN INCREASED | 2 0.02 86.83 SEXUAL ABUSE | 1 0.01 86.84 SEXUAL DYSFUNCTION | 2 0.02 86.86 SHOCK | 12 0.12 86.98 SHOCK HAEMORRHAGIC | 1 0.01 86.99 SHORT-BOWEL SYNDROME | 1 0.01 87.00 SIALOADENITIS | 1 0.01 87.01 SICCA SYNDROME | 1 0.01 87.02 SICK SINUS SYNDROME | 2 0.02 87.04 SIGMOIDITIS | 1 0.01 87.05 SINGLE FUNCTIONAL KIDNEY | 1 0.01 87.06 SINUS ARREST | 1 0.01 87.07 SINUS ARRHYTHMIA | 1 0.01 87.08 SINUS BRADYCARDIA | 1 0.01 87.09 SINUS DISORDER | 2 0.02 87.11 SINUS TACHYCARDIA | 13 0.13 87.24 SINUSITIS | 5 0.05 87.29 SJOGREN'S SYNDROME | 1 0.01 87.30 SKIN BURNING SENSATION | 1 0.01 87.31 SKIN CANCER | 1 0.01 87.32 SKIN DISCOLOURATION | 7 0.07 87.39 SKIN DISORDER | 2 0.02 87.41 SKIN EROSION | 1 0.01 87.42 SKIN EXFOLIATION | 10 0.10 87.52 SKIN HAEMORRHAGE | 1 0.01 87.53 SKIN HYPERPIGMENTATION | 1 0.01 87.54 SKIN INDURATION | 1 0.01 87.55 SKIN INFLAMMATION | 2 0.02 87.57 SKIN IRRITATION | 1 0.01 87.58 SKIN LACERATION | 1 0.01 87.59 SKIN LESION | 3 0.03 87.62 SKIN NECROSIS | 1 0.01 87.63 SKIN NODULE | 3 0.03 87.66 SKIN ODOUR ABNORMAL | 1 0.01 87.67 SKIN PAPILLOMA | 1 0.01 87.68 SKIN REACTION | 1 0.01 87.69 SKIN STRIAE | 1 0.01 87.70 SKIN SWELLING | 2 0.02 87.72 SKIN TEST POSITIVE | 1 0.01 87.73 SKIN TOXICITY | 2 0.02 87.75 SKIN ULCER | 3 0.03 87.78 SKIN ULCER HAEMORRHAGE | 1 0.01 87.79 SKIN WARM | 1 0.01 87.80 SLEEP APNOEA SYNDROME | 1 0.01 87.81 SLEEP DISORDER | 5 0.05 87.86 SLEEP WALKING | 1 0.01 87.87 SMALL FOR DATES BABY | 3 0.03 87.90 SMALL INTESTINAL OBSTRUCTION | 2 0.02 87.92 SMALL INTESTINAL ULCER HAEMORRHAGE | 1 0.01 87.93 SMALL INTESTINE CARCINOMA | 1 0.01 87.94 SNEEZING | 1 0.01 87.95 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 87.96 SOCIAL PHOBIA | 2 0.02 87.98 SOLAR ELASTOSIS | 1 0.01 87.99 SOMATOSENSORY EVOKED POTENTIALS ABNOR.. | 1 0.01 88.00 SOMNOLENCE | 88 0.88 88.88 SPECIFIC GRAVITY URINE INCREASED | 1 0.01 88.89 SPEECH DISORDER | 16 0.16 89.05 SPINA BIFIDA | 1 0.01 89.06 SPINAL CORD DISORDER | 1 0.01 89.07 SPINAL CORD INFARCTION | 1 0.01 89.08 SPINAL CORD INJURY | 1 0.01 89.09 SPINAL CORD NEOPLASM | 1 0.01 89.10 SPINAL FRACTURE | 5 0.05 89.15 SPINAL OPERATION | 1 0.01 89.16 SPINAL OSTEOARTHRITIS | 1 0.01 89.17 SPLENIC INFARCTION | 1 0.01 89.18 SPLENIC LESION | 1 0.01 89.19 SPLENIC RUPTURE | 1 0.01 89.20 SPLENOMEGALY | 6 0.06 89.26 SPONTANEOUS HAEMATOMA | 1 0.01 89.27 SPUTUM CULTURE POSITIVE | 2 0.02 89.29 SPUTUM DISCOLOURED | 1 0.01 89.30 SQUAMOUS CELL CARCINOMA | 2 0.02 89.32 STAPHYLOCOCCAL INFECTION | 14 0.14 89.46 STAPHYLOCOCCAL SCALDED SKIN SYNDROME | 1 0.01 89.47 STAPHYLOCOCCAL SEPSIS | 1 0.01 89.48 STATUS EPILEPTICUS | 1 0.01 89.49 STEVENS-JOHNSON SYNDROME | 13 0.13 89.62 STIFF-MAN SYNDROME | 1 0.01 89.63 STILLBIRTH | 5 0.05 89.68 STOMACH DISCOMFORT | 5 0.05 89.73 STOMATITIS | 14 0.14 89.87 STRABISMUS | 1 0.01 89.88 STREPTOCOCCAL SEPSIS | 1 0.01 89.89 STRESS | 7 0.07 89.96 STRESS AT WORK | 2 0.02 89.98 STUPOR | 1 0.01 89.99 SUBARACHNOID HAEMORRHAGE | 2 0.02 90.01 SUBCLAVIAN VEIN THROMBOSIS | 2 0.02 90.03 SUBDURAL HAEMATOMA | 3 0.03 90.06 SUBDURAL HAEMORRHAGE | 1 0.01 90.07 SUBILEUS | 1 0.01 90.08 SUBSTANCE ABUSE | 1 0.01 90.09 SUDDEN CARDIAC DEATH | 1 0.01 90.10 SUDDEN DEATH | 5 0.05 90.15 SUDDEN HEARING LOSS | 1 0.01 90.16 SUDDEN INFANT DEATH SYNDROME | 1 0.01 90.17 SUICIDAL BEHAVIOUR | 1 0.01 90.18 SUICIDAL IDEATION | 15 0.15 90.33 SUICIDE ATTEMPT | 15 0.15 90.48 SUNBURN | 1 0.01 90.49 SUPERINFECTION | 2 0.02 90.51 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 90.54 SUPRAVENTRICULAR TACHYCARDIA | 6 0.06 90.60 SURGERY | 9 0.09 90.69 SURGICAL PROCEDURE REPEATED | 1 0.01 90.70 SWELLING | 11 0.11 90.81 SWELLING FACE | 4 0.04 90.85 SWOLLEN TONGUE | 4 0.04 90.89 SYMBLEPHARON | 1 0.01 90.90 SYNCOPE | 21 0.21 91.11 SYNCOPE VASOVAGAL | 5 0.05 91.16 SYNDACTYLY | 1 0.01 91.17 SYNOVIAL CYST | 2 0.02 91.19 SYSTEMIC CANDIDA | 1 0.01 91.20 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 91.23 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 91.24 T-CELL PROLYMPHOCYTIC LEUKAEMIA | 1 0.01 91.25 TACHYCARDIA | 37 0.37 91.62 TACHYPNOEA | 3 0.03 91.65 TARDIVE DYSKINESIA | 1 0.01 91.66 TEARFULNESS | 2 0.02 91.68 TELANGIECTASIA | 1 0.01 91.69 TEMPERATURE INTOLERANCE | 2 0.02 91.71 TEMPOROMANDIBULAR JOINT SYNDROME | 2 0.02 91.73 TENDERNESS | 3 0.03 91.76 TENDON DISORDER | 2 0.02 91.78 TENDON RUPTURE | 4 0.04 91.82 TENDONITIS | 5 0.05 91.87 TENSION HEADACHE | 1 0.01 91.88 TERATOGENICITY | 2 0.02 91.90 TESTICULAR DISORDER | 1 0.01 91.91 TESTICULAR PAIN | 1 0.01 91.92 THALASSAEMIA TRAIT | 1 0.01 91.93 THEFT | 1 0.01 91.94 THERAPEUTIC AGENT TOXICITY | 5 0.05 91.99 THERAPEUTIC PROCEDURE | 1 0.01 92.00 THERAPEUTIC PRODUCT INEFFECTIVE | 1 0.01 92.01 THERAPEUTIC RESPONSE DECREASED | 4 0.04 92.05 THERAPEUTIC RESPONSE UNEXPECTED | 1 0.01 92.06 THERAPY REGIMEN CHANGED | 1 0.01 92.07 THERMAL BURN | 1 0.01 92.08 THINKING ABNORMAL | 6 0.06 92.14 THIRST | 6 0.06 92.20 THORACIC CAVITY DRAINAGE | 1 0.01 92.21 THROAT IRRITATION | 3 0.03 92.24 THROAT TIGHTNESS | 2 0.02 92.26 THROMBOCYTOPENIA | 29 0.29 92.55 THROMBOCYTOPENIA NEONATAL | 1 0.01 92.56 THROMBOPHLEBITIS | 5 0.05 92.61 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.62 THROMBOSIS | 16 0.16 92.78 THROMBOTIC MICROANGIOPATHY | 1 0.01 92.79 THROMBOTIC STROKE | 1 0.01 92.80 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 92.81 THYMOMA | 1 0.01 92.82 THYROID CANCER | 1 0.01 92.83 THYROID DISORDER | 1 0.01 92.84 THYROID NEOPLASM | 1 0.01 92.85 THYROIDECTOMY | 1 0.01 92.86 THYROXINE INCREASED | 1 0.01 92.87 TIBIA FRACTURE | 1 0.01 92.88 TIC | 2 0.02 92.90 TINNITUS | 6 0.06 92.96 TONGUE DISORDER | 4 0.04 93.00 TONGUE OEDEMA | 2 0.02 93.02 TONGUE PARALYSIS | 1 0.01 93.03 TONSILLAR HYPERTROPHY | 2 0.02 93.05 TOOTH DISCOLOURATION | 1 0.01 93.06 TOOTH DISORDER | 4 0.04 93.10 TOOTH EXTRACTION | 9 0.09 93.19 TOOTH LOSS | 2 0.02 93.21 TOOTHACHE | 2 0.02 93.23 TORSADE DE POINTES | 3 0.03 93.26 TORTICOLLIS | 2 0.02 93.28 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 93.32 TOXIC SKIN ERUPTION | 3 0.03 93.35 TOXOPLASMOSIS | 1 0.01 93.36 TRACHEAL CANCER | 1 0.01 93.37 TRACHEAL OEDEMA | 1 0.01 93.38 TRACHEAL PAIN | 1 0.01 93.39 TRACHEOSTOMY | 1 0.01 93.40 TRANSAMINASES INCREASED | 9 0.09 93.49 TRANSFUSION | 1 0.01 93.50 TRANSFUSION REACTION | 1 0.01 93.51 TRANSIENT ISCHAEMIC ATTACK | 14 0.14 93.65 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 93.66 TRAUMATIC BRAIN INJURY | 1 0.01 93.67 TREATMENT NONCOMPLIANCE | 2 0.02 93.69 TREMOR | 44 0.44 94.13 TRI-IODOTHYRONINE FREE INCREASED | 1 0.01 94.14 TRICHIASIS | 1 0.01 94.15 TRICUSPID VALVE DISEASE | 1 0.01 94.16 TRICUSPID VALVE INCOMPETENCE | 3 0.03 94.19 TRISMUS | 3 0.03 94.22 TRISOMY 21 | 1 0.01 94.23 TROPONIN INCREASED | 3 0.03 94.26 TRUNCUS ARTERIOSUS PERSISTENT | 1 0.01 94.27 TUBERCULOSIS | 6 0.06 94.33 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 94.34 TUMOUR LYSIS SYNDROME | 2 0.02 94.36 ULCER | 4 0.04 94.40 ULCERATIVE KERATITIS | 1 0.01 94.41 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 2 0.02 94.43 ULTRASOUND DOPPLER ABNORMAL | 1 0.01 94.44 ULTRASOUND KIDNEY ABNORMAL | 1 0.01 94.45 UMBILICAL CORD PROLAPSE | 1 0.01 94.46 UNINTENDED PREGNANCY | 2 0.02 94.48 UNRESPONSIVE TO STIMULI | 1 0.01 94.49 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 94.53 UPPER LIMB FRACTURE | 1 0.01 94.54 UPPER RESPIRATORY TRACT INFECTION | 2 0.02 94.56 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 94.57 URETERIC OBSTRUCTION | 1 0.01 94.58 URETHRAL PAIN | 1 0.01 94.59 URINARY BLADDER POLYP | 1 0.01 94.60 URINARY INCONTINENCE | 10 0.10 94.70 URINARY RETENTION | 4 0.04 94.74 URINARY TRACT INFECTION | 17 0.17 94.91 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 94.92 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 94.93 URINARY TRACT INFECTION STAPHYLOCOCCAL | 1 0.01 94.94 URINE ABNORMALITY | 1 0.01 94.95 URINE BILIRUBIN INCREASED | 1 0.01 94.96 URINE CALCIUM DECREASED | 1 0.01 94.97 URINE COLOUR ABNORMAL | 2 0.02 94.99 URINE KETONE BODY PRESENT | 1 0.01 95.00 URINE OUTPUT DECREASED | 1 0.01 95.01 URINE SODIUM INCREASED | 1 0.01 95.02 UROSEPSIS | 2 0.02 95.04 URTICARIA | 16 0.16 95.20 URTICARIA GENERALISED | 3 0.03 95.23 UTERINE ENLARGEMENT | 1 0.01 95.24 UTERINE INFLAMMATION | 1 0.01 95.25 UTERINE LEIOMYOMA | 6 0.06 95.31 UTERINE PERFORATION | 1 0.01 95.32 UTERINE POLYP | 1 0.01 95.33 UTERINE PROLAPSE | 1 0.01 95.34 VACCINATION COMPLICATION | 2 0.02 95.36 VAGINAL CANCER | 1 0.01 95.37 VAGINAL CANDIDIASIS | 2 0.02 95.39 VAGINAL DISORDER | 1 0.01 95.40 VAGINAL HAEMORRHAGE | 4 0.04 95.44 VAGINAL INFECTION | 1 0.01 95.45 VAGINITIS BACTERIAL | 1 0.01 95.46 VARICOCELE | 1 0.01 95.47 VARICOSE VEIN | 1 0.01 95.48 VARICOSE VEIN OPERATION | 1 0.01 95.49 VASCULAR BYPASS GRAFT | 1 0.01 95.50 VASCULAR CALCIFICATION | 1 0.01 95.51 VASCULAR CAUTERISATION | 1 0.01 95.52 VASCULAR GRAFT COMPLICATION | 1 0.01 95.53 VASCULAR MALFORMATION PERIPHERAL | 1 0.01 95.54 VASCULAR PROCEDURE COMPLICATION | 1 0.01 95.55 VASCULAR PSEUDOANEURYSM | 1 0.01 95.56 VASCULAR RUPTURE | 1 0.01 95.57 VASCULITIS | 4 0.04 95.61 VASOCONSTRICTION | 1 0.01 95.62 VEIN DISORDER | 3 0.03 95.65 VEIN WALL HYPERTROPHY | 1 0.01 95.66 VENA CAVA THROMBOSIS | 3 0.03 95.69 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 95.70 VENOUS STENOSIS | 1 0.01 95.71 VENOUS THROMBOSIS | 2 0.02 95.73 VENOUS THROMBOSIS LIMB | 1 0.01 95.74 VENTRICULAR EXTRASYSTOLES | 3 0.03 95.77 VENTRICULAR FIBRILLATION | 1 0.01 95.78 VENTRICULAR FLUTTER | 1 0.01 95.79 VENTRICULAR HYPERTROPHY | 2 0.02 95.81 VENTRICULAR HYPOKINESIA | 1 0.01 95.82 VENTRICULAR SEPTAL DEFECT | 4 0.04 95.86 VENTRICULAR TACHYCARDIA | 6 0.06 95.92 VERTIGO | 11 0.11 96.03 VERTIGO POSITIONAL | 1 0.01 96.04 VESICAL FISTULA | 1 0.01 96.05 VICTIM OF CRIME | 1 0.01 96.06 VIRAL INFECTION | 7 0.07 96.13 VISCERAL LEISHMANIASIS | 1 0.01 96.14 VISION BLURRED | 29 0.29 96.43 VISUAL ACUITY REDUCED | 27 0.27 96.70 VISUAL DISTURBANCE | 17 0.17 96.87 VISUAL FIELD DEFECT | 1 0.01 96.88 VITAL FUNCTIONS ABNORMAL | 1 0.01 96.89 VITAMIN B12 DEFICIENCY | 1 0.01 96.90 VITAMIN D DECREASED | 1 0.01 96.91 VITH NERVE PARALYSIS | 1 0.01 96.92 VITRECTOMY | 1 0.01 96.93 VITREOUS HAEMORRHAGE | 1 0.01 96.94 VITRITIS | 1 0.01 96.95 VOCAL CORD PARALYSIS | 2 0.02 96.97 VOMITING | 168 1.68 98.65 VOMITING PROJECTILE | 1 0.01 98.66 VULVOVAGINAL DISCOMFORT | 2 0.02 98.68 WALKING AID USER | 2 0.02 98.70 WATER INTOXICATION | 1 0.01 98.71 WEANING FAILURE | 1 0.01 98.72 WEIGHT BEARING DIFFICULTY | 1 0.01 98.73 WEIGHT DECREASED | 37 0.37 99.10 WEIGHT INCREASED | 25 0.25 99.35 WHEEZING | 6 0.06 99.41 WHITE BLOOD CELL COUNT DECREASED | 20 0.20 99.61 WHITE BLOOD CELL COUNT INCREASED | 21 0.21 99.82 WHITE BLOOD CELL DISORDER | 2 0.02 99.84 WHITE BLOOD CELLS URINE POSITIVE | 2 0.02 99.86 WOUND | 2 0.02 99.88 WOUND DEBRIDEMENT | 1 0.01 99.89 WRIST FRACTURE | 1 0.01 99.90 WRONG DRUG ADMINISTERED | 4 0.04 99.94 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 2 0.02 99.96 X-RAY ABNORMAL | 1 0.01 99.97 X-RAY OF PELVIS AND HIP ABNORMAL | 1 0.01 99.98 YAWNING | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015